Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology | Musculoskeletal
Clinical Trials: Leukemia
A listing of clinical trials currently looking for volunteers to enroll in Leukemia studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : University of Alabama Comprehensive Cancer Center University of Alabama
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Birmingham : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Birmingham : University of Alabama Comprehensive Cancer Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Birmingham : University of Alabama at Birmingham
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Birmingham : University of Alabama at Birmingham
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
View More »
Birmingham : University of Alabama, Birmingham
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Birmingham : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Birmingham : University Of Alabama At Birmingham
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Huntsville : Clearview Cancer Institute
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Huntsville : Clearview Cancer Institute
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Huntsville : Clearview Cancer Institute
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Huntsville : Clearview Cancer Institute
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Huntsville : Clearview Cancer Institute
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Huntsville : Clearview Cancer Institute
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Huntsville : TG Therapeutics Investigational Trial Site
Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies
Muscle Shoals : Northwest Alabama Cancer Center, PC
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Muscle Shoals : Northwest Alabama Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Arizona
Phoenix : Phoenix Children'S Hospital
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Phoenix :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Phoenix : Phoenix Children's Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Scottsdale : Mayo Clinic Arizona - Cancer Clinical Research Unit
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Scottsdale : Site Reference ID/Investigator# 59324
ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies
View More »
Scottsdale : Virginia G. Piper Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Scottsdale : Mayo Clinic
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Scottsdale : Call for Information (Investigational Site 0004)
Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)
Sedona : Arizona Oncology Associates, PC - NAHOA
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Tucson : Arizona Oncology Associates
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Tucson : Arizona Oncology Associates
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Tucson : University of Arizona (SPORE)
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Tucson : Arizona Oncology Associates, PC - HOPE
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Arkansas
Fayetteville : Highlands Oncology Group
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
Hot Springs : Investigational Site Number 840018
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Hot Springs National Park : Genesis Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Jonesboro : GSK Investigational Site
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Jonesboro : NEA Baptist Clinic
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
View More »
Little Rock : University Of Arkansas For Medical Sciences
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Little Rock : Little Rock Hematology Oncology Associates
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
California
Duarte : City of Hope
An Open Label, Multicenter, Phase II Study to Evaluate Efficacy and Safety of the BiTE Antibody Blinatumomab in Adult Patients with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)
Duarte : City of Hope
COG #AALL0434: Intensified Methotrexate, Nelarabine (Compound 506U78; IND #52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia
Duarte : City of Hope
COG AALL08B1 - Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Duarte : City of Hope
COG AALL0932: Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymhoblastic Leukemia (ALL)
Duarte : City of Hope
COG AALL1131: A Phase III Randomized Trial for Newly Diagnosed High Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)Testing Clofarabine (IND#73789, NSC# 606869) in the Very High Risk Stratum
Duarte : City of Hope
Immune Responses in Acute Leukemia and Chronic Myeloid Leukemia
Duarte : City of Hope
Mechanisms of Response and Resistance to STI571 in CML
Duarte : City of Hope
Molecular Pathogenesis of Acute Leukemia and Myelodysplasia
Duarte : City of Hope
Molecular Pathogenesis of Therapy-Related Leukemia
Duarte : City of Hope
SWOG S0805: Phase II Study of Combination of Hyper-CVAD and Dasatinib (NSC-732517) with or without Allogeneic Stem Cell Transplant in Patients with Philadelphia (Ph) Chromosome Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL) (A BMT Study)
Duarte : City of Hope
SWOG S1117: A Randomized Phase II Study of Azacitidine in Combination with Lenalidomide (NSC-703813) vs. Azacitidine Alone vs. Azacitidine in Combination with Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
View More »
Anaheim : Pacific Cancer Medical Center, Inc.
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Anaheim : Pacific Cancer Medical Center, Inc
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Burbank : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Burbank : East Valley Hematology and Oncology Medical Group
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Burbank : US Oncology - Providence Health System, Site #167 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Concord : Bay Area Cancer Research Group
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Duarte : City of Hope
A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)
Duarte : City of Hope
A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Duarte : City of Hope
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Duarte : City of Hope National Medical Center
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Duarte : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Escondido : Southwest Cancer Care Medical Group
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Escondido : Southwest Cancer Care Medical Group
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Fountain Valley : Pacific Coast Hematology/Oncology Medical Group, Inc.
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Fountain Valley : Robert A. Moss, M.D. FACP, Inc.
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Fountain Valley : Lalita Pandit, MD, Inc.
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Glendora : Wilshire Oncology Medical Group, Inc
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Hayard : Kaiser Permanente Northern California
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
La Jolla : University of California, San Diego - Moores Cancer Center
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
La Jolla : Site Reference ID/Investigator# 48325
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
La Jolla : Site Reference ID/Investigator# 70398
A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed or Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
La Jolla : Moores UCSD Cancer Center
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
La Jolla : Univ. of San Diego: Moores UCSD Cancer Center
A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
La Jolla : University of California, San Diego/Moores Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
La Jolla : University of California, San Diego- Moores Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
La Jolla : Scripps Cancer Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
La Jolla : Scripps Cancer Center
A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia
La Jolla : Moores UCSD Cancer Center
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
La Jolla : Moores Ucsd Cancer Center
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
La Jolla : University of California, San Diego
Multi-center Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
La Jolla : University of California San Diego
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
La Jolla : Danelle James, M.D.
Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)
La Jolla : University of California San Diego, Moores Cancer Center
Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)
La Jolla : University of California San Diego Moores Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
La Jolla : Moores UCSD Cancer Center
Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia
La Jolla : University of California, San Diego
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
La Jolla : Moores UCSD Cancer Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
La Jolla : UCSD Medical Center
Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)
La Jolla : Moores UCSD Cancer Center
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Loma Linda : Antranik Agop Bedros
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Long Beach : Jonathan Jaques Children'S Cancer Center
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Long Beach : Miller Children's Hospital Long Beach
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Long Beach : Miller Children's Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Los Angeles : UCLA
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Los Angeles : Childrens Hospital Los Angeles
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Los Angeles : Children's Hospital of Los Angeles
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Los Angeles : Investigational Site Number 840012
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Los Angeles : UCLA Ronald Reagan Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Los Angeles : Childrens Hospital Los Angeles
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Los Angeles : Childrens Hospital Los Angeles
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
Los Angeles : Cedars-Sinai Medical Center
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
Los Angeles : UCLA
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Los Angeles : UCLA School of Medicine
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Los Angeles : Metropolitan Hematology Oncology Medical Group
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Los Angeles : UCLA Division of Hematology-Oncology
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Los Angeles : Ucla-Division Of Hematology/Oncology
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
Los Angeles : Cedars-Sinai Medical Center
KW 0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
Los Angeles : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Los Angeles : Children'S Hospital Of L.A.
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Los Angeles : Division Of Hematology & Oncology Ctr. For Health Sciences
Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy
Los Angeles : University of Southern California
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Los Angeles : UCLA Division of Hematology/Oncology
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Los Angeles : UCLA
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Los Angeles : University of Southern California
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Los Angeles : Childrens Hospital Los Angeles
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Madera :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Mission Hills : Providence Holy Cross Medical Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Oakland : Oakland Children's Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Oceanside : North County Oncology
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Orange : Children's Hospital of Orange County CHOC
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Orange : Children'S Hospital Of Orange County
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Orange : Children's Hospital of Orange County CHOC Cancer Institute
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
Orange : Children'S Hospital Of Orange County
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Orange County : Children's Hospital of Orange County
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Oxnard : Ventura County Hematology Oncology Specialists
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Oxnard : Ventura County Hematology Oncology Specialists
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Oxnard : PMK Medical Group Inc., DBA Ventura County Hematology Oncology Specialists
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Oxnard : Ventura County Hematology Oncology Specialists
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Oxnard : PMK Medical Group, Inc. DBA Ventura
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Palm Springs : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Palo Alto : Stanford University Medical Center Oncology
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Palo Alto : Stanford Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Palo Alto : Stanford Medical Center
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Palo Alto : Stanford Cancer Center
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Palo Alto : Stanford University Medical Center
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Palo Alto : Lpch & Sumc
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Palo Alto : Stanford Cancer Center
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Palo Alto : Stanford University Medical Center
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Poway : Southwest Cancer Care Murrieta
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
Rancho Mirage : Cancer and Blood Institute Medical Group
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Roseville : Kaiser Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Sacramento : Univeristy of California Davis Medical Center
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
Sacramento : University of California Comprehensive Cancer Center
Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia
Sacramento : University of California Comprehensive Cancer Center
Phase I Study of Lenalidomide in Patients With Acute Leukemia
Sacramento : University of California Davis
Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
San Diego : Kaiser Permanente Medical Group
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
San Diego : Rady Children's Hospital
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
San Diego : Moores UCSD Cancer Center
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
San Diego : Sharp Clinical Oncology Research
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
San Francisco : UCSF School of Medicine
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
San Francisco : University Of California Medical Center
Dasatinib Combo With SMO Inhibitor (BMS-833923)
San Francisco : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
San Francisco : UCSF Helen Diller Family Family Comprehensive Cancer Center
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
San Francisco : University of California Medical Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
San Francisco : University of California San Francisco
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
San Francisco : UCSF School of Medicine
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
San Luis Obispo : (200) Coastal Integrative Cancer Care
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
San Pablo : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Santa Maria : Central Coast Medical Oncology Corp.
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Santa Monica : UCLA Medical Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Santa Monica : UCLA
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Santa Monica, : Sarcoma Oncology Center
Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia
Stanford : Stanford Cancer Center
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Stanford : Stanford University School of Medicine
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Stanford : Stanford Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Stanford : (125) University of Stanford
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
Stanford : Stanford Cancer Center - Stanford University
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Stanford :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Stanford :
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma
Stanford : Stanford Cancer Center
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Stanford : Stanford University
A Trial of the Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)
Stanford : Stanford University School of Medicine
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
Stanford : Stanford University School of Medicine
Azacitidine + Lenalidomide Combo in the Elderly Previously Treated Acute Myeloid Leukemia (AML) & High-Risk Myelodysplastic Syndromes (MDS)
Stanford : Stanford University Medical Center
MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
Stanford : Stanford University School of Medicine
Phase II Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma
Stanford : Stanford University School of Medicine
Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia
Stanford : Stanford Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Stanford : Stanford University Medical Center Stanford U
Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
Stanford : Stanford University Medical Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Stanford : Pfizer Investigational Site
Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia
Stanford : Stanford University Medical Center, BMT
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Stockton : St. Teresa Comprehensive Cancer Center
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Vista : Medical Group of North County
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Yorba Linda : St. Jude Heritage Medical Group Virginia Crosson Cancer Center
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Colorado
Aurora : Children'S Hospital
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Aurora : (115) University of Colorado Anschultz Cancer Center
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
Aurora : Children's Hospital
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Aurora : Pfizer Investigational Site
A Trial In Patients With Advanced Cancer And Leukemia
Aurora :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
View More »
Aurora : Children'S Hospital Colorado
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Aurora : Investigational Site Number 840004
Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia
Boulder : Rocky Mountain Cancer Centers
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Colorado Springs : The Oncology Clinic, PC
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Denver : Rocky Mountain Blood and Marrow Transplant Program
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Denver : Rocky Mountain Cancer Center
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Denver : Rocky Mountain Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Denver : Rocky Mountain Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Denver : Rocky Mountain Blood and Marrow Transplant Program
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Denver :
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma
Denver : Rocky Mountain Cancer Centers - Denver
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Denver : Mile High Oncology
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Denver : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Denver : HCA HealthONE - Rocky Mountain Blood and Marrow Transplant Program
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Connecticut
Hartford : Connecticut Children'S Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Manchester : Medical Oncology and Blood Disorders, LLP
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New Britain : The Hospital of Central Connecticut
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
New Haven : Yale Cancer Center
Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia
New Haven : Yale Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
View More »
Norwalk : Whittingham Cancer Center at Norwalk Hospital
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Norwalk : Norwalk Hospital
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Southington : Cancer Center of Central Connecticut
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Southington : Cancer Center of Central Connecticut
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Southington : Cancer Center of Central Connecticut
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Delaware
Wilmington : A. I. Dupont Hospital For Children
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
District of Columbia
Washington : Georgetown University Medical Center Lombardi Cancer Center
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Washington : Georgetown University Medical Center Lombardi Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Washington :
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma
Washington : Georgetown University
Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Washington : Children'S National Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
View More »
Washington : Georgetown University Hospital
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Washington : George Washington University-Medical Faculty Associates
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Washington : Georgetown University Hospital/Lombardi Cancer Center
Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
Florida
Atlantis : Medical Specialists of the Palm Beaches
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Boca Raton : Boca Raton Community Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Boynton Beach : Collaborative Research Group
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Boynton Beach : Collaborative Research Group LLC
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Boynton Beach : Thomas Niederman, MD
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
View More »
Boynton Beach : University Cancer Institute
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Boynton Beach : Palm Beach Institute of Hematology and Oncology
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Boynton Beach : University Cancer Institute, Site #149 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Boynton Beach : Hematology And Medical Oncology Of Southern Palm Beach County
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Fort Lauderdale : Holy Cross Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Fort Myers : Florida Cancer Specialists
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Fort Myers : Florida Cancer Specialists
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Fort Myers : Lee Memorial Health System
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Gainsville : University of Florida
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Gainsville : University of Florida
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Hialeah : Palm Springs Research Institute
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Jacksonville : Mayo Clinic Jacksonville
A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)
Jacksonville : Integrated Community Oncology Network
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Jacksonville : Mayo Clinic
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Jacksonville : Nemours Children'S Clinic
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Jacksonville : Integrated Community Oncology Network
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Jacksonville : Baptist Cancer Institute
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Jacksonville : Baptist Cancer Institute
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Kissimmee : Osceola Cancer Center
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Lakeland : Watson Clinic
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Miami : University of Miami
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Miami :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Miami : Innovative Medical Research of South Florida, Inc.
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Miami : University of Miami Cancer Center
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Miami Beach : (145) Mount Sinai Comprehensive Cancer Center
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
Miami Beach : Mount Sinai Comprehensive Cancer Centers
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
New Port Richey : Florida Cancer Institute
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
New Port Richey : Pasco Hernando Oncology Associates (Kumar)
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
New Port Richey : Pasco Pinellas Cancer Center
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
New Port Richey : Pasco Hernando Oncology Associates, PA
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
New Port Richey : Florida Cancer Specialists
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Ocala : Ocala Oncology Center
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Ocoee : Cancer Centers of Florida PA Cancer Centers of FL-Orlando-4
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
Orlando : Md Anderson Cancer Center Orlando
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Orlando : Nemours Children'S Clinic - Orlando
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Orlando : Cancer Centers of Florida
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Pembroke Pines : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Pensacola : Investigational Site Number 840016
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Pensacola : Woodlands Medical Specialists
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Sarasota :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
St. Petersburg : Florida Cancer Specialists
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
St. Petersburg : Florida Cancer Specialists
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
St. Petersburg : All Children'S Hospital
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
St. Petersburgh : All Children's Hospital
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Stuart : Martin Memorial Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Tampa : H. Lee Moffitt Cancer Center & Research Institute
CNDO-109-AANK for AML in First Complete Remission (CR1)
Tampa : H. Lee Moffitt Cancer Center & Research Institute
Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)
Tampa : H. Lee Moffitt Cancer Center and Research Institute
Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Tampa : H. Lee Moffitt Cancer Center and Research Institute
Phase II Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Tampa : Moffitt Cancer Center
Study of KB004 in Subjects With Hematologic Malignancies
Tampa : Call for Information (Investigational Site 0006)
Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)
Tampa : H. Lee Moffitt Cancer Center
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
Tampa : Moffitt Cancer Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Tampa : H. Lee Moffitt Cancer Center & Research Institute
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Tavares : Lake County Oncology and Hematology
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Tavares : Lake County Oncology and Hematology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Titusville : Space Coast Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
West Palm Beach : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Weston : Cleveland Clinic Florida
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Weston : Cleveland Clinic Florida
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Georgia
Albany : Phoebe Putney Memorial Hospital
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Atlanta : Emory University, Winship Cancer Institute
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Atlanta : Aflac Cancer Center & Blood Disorders Service
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Atlanta : Emory University, Winship Cancer Institute
A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Atlanta : Emory University, Winship Cancer Institute
A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
View More »
Atlanta : Blood and Marrow Transplant Group of Georgia
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Atlanta : Winship Cancer Institute, Emory University
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Atlanta : Northside Hospital/BMTGA
A Trial of the Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)
Atlanta : Site Reference ID/Investigator# 26523
ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies
Atlanta : Winship Cancer Institute of Emory University
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Atlanta : Georgia Cancer Specialists
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Atlanta : Peachtree Hematology-Oncology Consultants
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Atlanta :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Atlanta : Winship Cancer Institute
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Atlanta : Emory University Winship Cancer Institute
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Atlanta : Emory University
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Atlanta : Children's Healthcare of Atlanta, Emory University
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Augusta : Investigational Site Number 840006
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Augusta : Georgia Health Sciences University
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Augusta : Augusta Oncology Associates, PC
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Augusta : For additional information regarding sites for this trial call (919) 465-4648
Phase 1b Safety and Efficacy Study of TRU-016 and Rituximab in Previously Untreated Chronic Lymphocytic Leukemia
Augusta : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Augusta : Investigational Site Number 840006
Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia
Augusta : Georgia Health Sciences University
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Dublin : US Oncology - Dublin Hematology & Oncology
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Griffin : Spalding Oncology Services
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Marietta :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Marietta : Northwest Georgia Oncology Centers, PC
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Sandy Springs : Georgia Cancer Specialist
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Savannah : Lewis Cancer Center and Research Pavilion
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
Hawaii
Honolulu : Straub Clinic and Hospital
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Honolulu : OnCare
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Honolulu : Straub Clinical & Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Idaho
Boise : St Luke's Mountain States Tumor Institute
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Post Falls : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Illinois
Elgin : Sherman Health
E2906 - Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age>/=60 Years
Elgin : Sherman Health
ECOG E2903 Phase II Trial of Pentostatin, Cyclophosphamide and Rituximab (PCR) Followed By Campath-1H For Previously Treated Relapsed or Refractory Patients With Chronic Lymphocytic Leukemia
Elgin : Sherman Health
S0919 - Phase II A Phase II Study of Idarubicin and Ara-C in Combination with Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
View More »
Arlington Heights : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Arlington
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Chicago : Ann & Robert H. Lurie Children's Hospital of Chicago Ann&Robert Lurie
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Chicago : Site Reference ID/Investigator# 71593
A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed or Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Chicago : University of Chicago
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Chicago : Northwestern University Fienberg School of Medicine
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Chicago : Children'S Memorial Hospital
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Chicago : Northwestern University
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Chicago : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Acute Leukemia
Chicago : Northwestern University
A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)
Chicago : Children's Memorial Hospital
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Chicago : Northwestern Memorial Hospital
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Chicago : The University of Chicago Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Chicago : Rush University Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Chicago : Ann & Robert H. Lurie Children's Hospital of Chicago SC
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
Chicago : Northwestern University
A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)
Chicago : Northwestern University
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Chicago : Northwestern University
Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia
Chicago : Northwestern University
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Chicago : University of Chicago
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Chicago : 1315.1.1003 Boehringer Ingelheim Investigational Site
BI 836858 Dose Escalation in Refractory or Relapsed Acute Myeloid Leukemia
Chicago : University of Chicago
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Chicago : University of Chicago
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Chicago : John H. Stroger, Jr., Hospital of Cook County
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Chicago : Rush University Medical Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Chicago : Northwestern University Feinberg School of Medicine
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Chicago : Rush University Medical Center
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Chicago : University of Chicago Cancer Research Center
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Chicago : Northwestern University
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Chicago : Robert H. Lurie Comprehensive Cancer Center Northwestern University
MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
Chicago : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Chicago : Children'S Hospital Of Chicago
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Chicago : Northwestern University
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Chicago : University of Chicago, Site #001 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Chicago : Rush University Medical Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Chicago : University of Chicago Medical Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Chicago : Children's Memorial Hospital
Reduced Intensity Transplant Using Extracorporeal Photopheresis
Chicago : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Chicago : Northwestern University
Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL
Chicago : University of Chicago Cancer Center
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Chicago : Pfizer Investigational Site
Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia
Chicago : Univerity of Chicago
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)
Chicago : University of Chicago Medical Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Chicago : Rush University Medical Center, Division of Hematology/Oncology
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Chicago : University of Chicago
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Chicago : Northwestern University
Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission
Evanston : North Shore Medical Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Evergreen Park : Mahafzah Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Gurnee : Oncology Hematology Assoc. of Northern Illinois
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Harvey : Ingalls Cancer Research Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Hines : Edward Hines Jr. VA Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Lombard : Elmhurst Memorial Hospital
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Maywood : Investigational Site Number 840011
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Maywood : Cardinal Bernardin Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Maywood : Loyola University Medical Center, Cardinal Bernardin Cancer Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Maywood : Loyola University Medical Center, Cardinal Bernardin Cancer Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Maywood : Loyola University Medical Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Niles : Oncology Specialists, S.C.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Niles : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Niles : Orchard Health Care Research
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Normal : Mid-Illinois Hem/Onc Asoc
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
North Chicago : North Chicago VA Medical Center
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
North Chicago : North Chicago VA Medical Center
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
North Chicago : North Chicago VA Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Peoria : Illinois Cancer Care
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Skokie : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Skokie : Hematology Oncology Assoc. of IL.
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Skokie : Orchard Research
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Skokie : Edward H. Kaplan MD & Associates
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Springfield : Southern Illinois University School Of Medicine
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Springfield : Southern Illinois School of Medicine
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Urbana : Carle Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Winfield : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Winfield
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Indiana
Anderson : Saint John's Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Beech Grove : St. Francis Hospital and Health Centers IndianaBlood&MarrowTransplantn
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
Beech Grove : St. Francis Cancer Research
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Beech Grove : Indiana Blood and Marrow Transplantation, LLC
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Goshen :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
View More »
Goshen : Center for Cancer Care @ Goshen Health Systems
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Indianapolis : Indiana University Riley Hospital for Children
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Indianapolis :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Indianapolis : St. Francis Medical Group Oncology and Hematology Specialits
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Indianapolis : Indiana University Simon Cancer Center IU Simon Cancer Center Clinical Research Office, RT 380
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Indianapolis : Indiana University Cancer Center Clinical Research Office
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Indianapolis : Indiana Oncology Hematology Consultants
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Indianapolis : James Whitcomb Riley Hospital For Children
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Indianapolis : Children'S Center For Cancer And Blood Diseases
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Indianapolis : Indiana University Melvin and Bren Simon Cancer Center
Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib for the Treatment of Acute Myeloid Leukemia With Complex- or Poor-risk (Monosomy 5/7) Cytogenetics or FLT3-ITD Positive Genotype
Indianapolis : Franciscan St. Francis Health
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Indianapolis : Indiana University Melvin and Bren Simon Cancer Center
Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia
Indianapolis : Franciscan St. Francis Health, Site #138 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Indianapolis : Indiana University Simon Cancer Center
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
Indianapolis : Indiana University Melvin and Bren Simon Cancer Center
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Indianapolis : St. Francis Medical Group Oncology and Hematology Specialists
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Indianapolis : Indiana Blood and Marrow Transplantation
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Indianapolis : Investigative Clinical Research of Indiana
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Lafayette : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Lafayette : Arnett Cancer Care
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Lafayette : Horizon Oncology Center
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Mishawaka : Cancer Care Partners, LLC
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
New Albany : Cancer Care Center, Inc.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
New Albany : Cancer Care Center
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
New Albany : Cancer Care Center, Inc. PC
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Iowa
Ames : McFarland Clinic
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Bettendorf : Hematology Oncology Associates of the Quad Cities
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Cedar Rapids : Iowa Blood and Cancer Care of PCI
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Iowa city : University of Iowa Hospitals and Clinics
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Iowa City : University of Iowa Hospitals and Clinics
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
View More »
Mason City : N. Iowa Mercy Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Waterloo : Covenant Clinic
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Kansas
Hutchinson : Hutchinson Clinic
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Kansas City : Investigational Site Number 840010
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Kansas City : University of Kansas Medical Center
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Kansas City : University of Kansas Medical Center, Westwood Campus
Safety Study: Combination of Decitabine and Midostaurin in Patients Older Than 60 With Newly Diagnosed or Relapsed Refractory Acute Myeloid Leukemia
Kansas City : University of Kansas Medical Center
Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease
View More »
Topeka : Cotton O'Neil Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Westwood : University of Kansas Medical Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Westwood : University of Kansas Medical Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Wichita : Cancer Center of Kansas, PA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Wichita : US Oncology - Cancer Center of Kansas, Site #168 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Wichita : Cancer Center of Kansas
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Witchita : Cancer Center of Kansas
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Kentucky
Hazard : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Hazard : Kentucky Cancer Clinic
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Lexington : Investigational Site Number 840013
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Lexington : Central Baptist Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Louisville : (175) University of Kentucky, Lousiville James Graham Brown Cancer Center
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
View More »
Louisville :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Paducah :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Paducah : Investigational Site Number 840007
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Paducah : Purchase Cancer Group
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Louisiana
Baton Rouge : Mary Bird Perkins Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Baton Rouge : Mary Bird Perkins Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Marrero :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Metairie : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
New Orleans : (195) Tulane University Hospital Tulane Cancer Center
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
View More »
New Orleans : Ochsner Medical Institutions
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
New Orleans : Tulane University Health Sciences Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
New Orleans : Ochsner Clinic Foundation
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Shreveport : Willis-Knighton Cancer System
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Maryland
Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk Myelodysplasia
Baltimore : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Baltimore : Sidney Kimmel Cancer Center at Johns Hopkins
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
Baltimore : John Hopkins
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Baltimore :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
View More »
Baltimore : University of Maryland Greenbaum Cancer Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Baltimore : Johns Hopkins Medical Institute
A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)
Baltimore : John Hopkins University
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Baltimore : University of Maryland Greenebaum Cancer Center
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Baltimore : Sidney Kimmel Cancer Center At Johns Hopkins
Dasatinib Combo With SMO Inhibitor (BMS-833923)
Baltimore :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Baltimore : Auerbach Hematology Oncology Associates, Inc.
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Baltimore : Greater Baltimore Medical Center
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Baltimore : Chesapeake Oncology Hematology Associates
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Baltimore : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Baltimore : B. Douglas Smith, M.D.
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
Baltimore : Johns Hopkins Kimmel Cancer Center
MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
Baltimore : Johns Hopkins University
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Baltimore : Greater Baltimore Medical Center, Site #140 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Baltimore : Johns Hopkins Hospital
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Baltimore : University of Maryland Greenebaum Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Baltimore : The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
Baltimore : Sidney Kimmel Comprehensive Cancer Center
Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
Baltimore : Call for Information (Investigational Site 0001)
Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)
Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Baltimore : Johns Hopkins University
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Bethesda : Research Site
A Phase I, Multicenter Dose Escalation Study in Patients With Leukemia
Bethesda : Center for Cancer & Blood Disorders, PC
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Bethesda : Research Site
CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Bethesda : National Institutes of Health Clinical Center, 9000 Rockville Pike
Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia
Bethesda : Center for Cancer and Blood Disorders
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Bethesda : National Institutes of Health Clinical Center, 9000 Rockville Pike
To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
Columbia : Maryland Oncology Hematology Pa
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Cumberland : Western Maryland Health System, Inc.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Westminster : Alliance Hematology Oncology, PA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Massachusetts
Boston : Site Reference ID/Investigator# 48324
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
Boston : Dana-Farber Cancer Institute
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Boston : Dana-Farber Cancer Institute
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Boston : Dana Farber Cancer Institute
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Boston : Investigational Site Number 840004
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
View More »
Boston : Investigational Site Number 840104
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Boston :
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma
Boston : Dana Farber Cancer Institute Deptof DanaFarberCancerInst(4)
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
Boston : Dana-Farber Cancer Institute
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Boston : Tufts University School of Medicine-Tufts Medical Center
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Boston : Beth Israel Deaconess Medical Center
Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)
Boston : Beth Israel Deaconess Medical Center
Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission
Boston : Dana-Farber Cancer Institute
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Boston : Research Site
CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Boston : Dana Farber Institute
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Boston : Dana Farber Cancer Institute and Children's Hospital
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Boston : Dana Farber Cancer Institute
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Boston : Beth Israel Deaconess Medical Center
Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Boston : Dana-Farber Cancer Institute
Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Boston : Massachusetts General Hospital
Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Boston :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Boston : Dana Farber Cancer Institute
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Boston : Dana-Farber Cancer Institute
Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL
Boston : Dana Farber Cancer Institute
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
Boston : Dana-Farber Cancer Institute
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
Boston : Dana Farber Cancer Institute
MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
Boston : Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Boston : Dana Farber Cancer Institute
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Boston : Dana Farber Cancer Institute
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Boston : Dana Farber Cancer Institute, Site #008 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Boston : Dana-Farber Cancer Institute
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Boston : Beth Israel Deaconess Medical Center
Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant
Boston : Massachusetts General Hospital
Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant
Boston : Dana Farber Cancer Institute Ctr. for Hematologic Oncology
Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
Boston : Research Site
Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients
Boston : Pfizer Investigational Site
Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia
Boston : Brigham & Women's Hospital
Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
Boston : Dana Farber Cancer Institute
Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
Boston : Beth Israel Deaconess Medical Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Boston : Dana-Farber Cancer Institute
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Boston : Massachusetts General Hospital
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Boston : Dana Farber Cancer Institute
Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Boston : Boston VA Healthcare System
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Boston : Beth Israel Deaconess Medical Center
Treatment of Older Adults With Acute Lymphoblastic Leukemia
Boston : Dana-Farber Cancer Institute
Treatment of Older Adults With Acute Lymphoblastic Leukemia
Boston : Massachusetts General Hospital
Treatment of Older Adults With Acute Lymphoblastic Leukemia
Boston : Dana Farber Cancer Institute
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Boston : Dana Farber
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Hyannis : Capecod Hospital / Davenport Mugar Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Quincy : Commonwealth Hematology-Oncology, P.C.
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Wocester :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Worcester : Fallon Clinic
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Worcester : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Worcester : University of Massachusetts Memorial Medical Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Michigan
Ann Arbor :
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma
Ann Arbor : University Of Michigan Health System
Dasatinib Combo With SMO Inhibitor (BMS-833923)
Ann Arbor : University of Michigan Comprehensive Cancer Center
MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
Ann Arbor : University of Michigan Cancer Center
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Ann Arbor : University of Michigan Comprehensive Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
View More »
Ann Arbor : University of Michigan Health System
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)
Ann Arbor : University of Michigan
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Ann Arbor : C.S. Mott Children's Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Detroit : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Detroit : Karmanos Cancer Institute
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Detroit : Karmanos Cancer Institute
A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Detroit : Karmanos Cancer Institute
A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
Detroit : Henry Ford Health System
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Detroit : Pfizer Investigational Site
A Trial In Patients With Advanced Cancer And Leukemia
Detroit : Barbara Ann Karmanos Cancer Institute
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Detroit : Children's Hospital of Michigan
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Detroit : Henry Ford Hospital
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Detroit : Children'S Hospital Of Michigan
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Detroit : Pfizer Investigational Site
Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia
Detroit : Henry Ford Health System
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Farmington Hills : Pfizer Investigational Site
Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia
Flint : Michigan State University / McLaren Regional Medical Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Flint : Genesee Cancer & Blood Disease Treatment Center, PC
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Freesoil : West Michigan Regional Cancer & Blood Center
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Grand Rapids : Cancer and Hematology Centers of Western Michigan
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Grand Rapids : Spectrum Health Hospitals
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Kalamazoo : West Michigan Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Kalamazoo : West Michigan Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Lansing : Michigan State University
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Minneapolis : University of Minnesota
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Southfield : Providence Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Minnesota
Duluth : Duluth Clinic Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Minneapolis : University of Minnesota
A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Minneapolis : Minnesota Oncology Hematology, PA
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Minneapolis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Acute Leukemia
Minneapolis : Children's Hospital and Clinics of Minnesota
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
View More »
Minneapolis : University of Minnesota
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Minneapolis : Masonic Cancer Center, University if Minnesota
Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
Minneapolis : Minnesota Oncology Hematology P.A.
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Minneapolis : Novartis Investigative Site
Safety and Tolerability of HSC835 in Patients With Hematological Malignancies
Minneapolis : University of Minnesota: Masonic Cancer Center, BMT Clinic, and Fairview Medical Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Minneapolis : University of Minnesota
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Minneapolis : Division of Hematology, Oncology and Transplantation University of Minnesota
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Minneapolis : University of Minnesota Children's Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Minneapolis : Childrens Hospital & Clinics of Minnesota
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Rochester : Mayo Clinic
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Rochester : Mayo Clinic
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Rochester : Mayo Clinic
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Rochester : Mayo Clinic
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Rochester : Mayo Clinic
Clinical Study of PM01183 in Patients With Acute Leukemia
Rochester : Mayo Clinic
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Rochester :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Rochester : Mayo Clinic
Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients
Rochester : Mayo Clinic
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
St. Louis Park : Park Nicollet Institute Metro - MN CCOP
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
St. Louis Park : Park Nicollet Institute - Louisiana Ave.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Mississippi
Jackson : Univ Of Mississippi Med Ctr
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Southaven : US Oncology - University of Tennessee Cancer Institute - Southaven
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Missouri
Branson : Branson Oncology Clinic
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Columbia : US Oncology - Missouri Cancer Associates
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Columbia : Ellis Fischel Cancer Center, University of Missouri Health Care
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Jefferson City : Capitol Comprehensive Cancer Care Clinic
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Kansas City : Saint Luke's Cancer Institute
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
View More »
Kansas City : The Children'S Mercy Hospital And Clinics
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Springfield : St. John's Medical Research Institute
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Springfield : Mercy Clinic - Cancer & Hematology, Site #151 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Springfield : St John's Clinic for Cancer and Hematology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
St Louis : Investigational Site Number 840015
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
St Louis : Washington University at St Louis
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
St. Joseph : St. Joseph Oncology, Inc.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
St. Louis : Washington University School of Medicine
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
St. Louis : (100) Washington University School of Medicine
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
St. Louis :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
St. Louis : St. Louis University Cancer Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
St. Louis : St. Louis University Cancer Center
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
St. Louis : Washington University School of Medicine
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
St. Louis : 1315.1.1004 Boehringer Ingelheim Investigational Site
BI 836858 Dose Escalation in Refractory or Relapsed Acute Myeloid Leukemia
St. Louis : Washington University School of Medicine
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
St. Louis : St. Louis University Cancer Center
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
St. Louis : Hematology Oncology Consultants, Inc.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
St. Louis : St. Louis Hematology Oncology Specialists, Inc.
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
St. Louis : Washington University Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
St. Louis : Washington University at St. Louis Siteman Cancer Center
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)
St. Louis : Washington University School of Medicine
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Montana
Billings : Call for Information (Investigational Site 0003)
A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714 AM2)
Billings : (150) Billings Clinic
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
Billings : Billings Clinic
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Missoula : Montana Cancer Institute Foundation
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Nebraska
Lincoln : Nebraska Hematology Oncology, PC
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Lincoln : Southeast Nebraska Hematology & Oncology Consultants, PC
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Lincoln : Nebraska Hematology-Oncology, P.C., Site # 133 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Omaha : Nebraska Medical Center
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Omaha : University of Nebraska Medical Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
View More »
Omaha : University of Nebraska Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Omaha : University of Nebraska Medical Center
Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
Omaha : University of Nebraska Medical Center University of Nebraska Med Ctr
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Omaha : University of Nebraska Medical Center
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Omaha : University of Nebraska Medical Center
Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma
Omaha : Omaha VAMC
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Nevada
Carson City : Sierra Nevada Oncology Care
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Henderson : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Las Vegas : Southern Nevada Cancer Research Foundation
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Las Vegas : Nevada Cancer Center
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Las Vegas : Children'S Specialty Center Of Nevada
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
View More »
Las Vegas : US Oncology - Comprehensive Cancer Center of Nevada, Site #169 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Las Vegas : Nevada Cancer Research Foundation
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Reno : VA Sierra Nevada Healthcare System
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
New Hampshire
Lebanon : Investigational Site Number 840017
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Lebanon : Dartmouth - Hitchcock Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Lebanon : Dartmouth-Hitchcock Medical Center
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Portsmouth : Portsmouth Regional Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New Jersey
Cherry Hill : The Center for Cancer and Hematologic Disease
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Cherry Hill : The Center for Cancer and Hematologic Disease
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Denville : Cancer Care at Saint Clare's/Saint Clares Hospital Oncology & Hematology Specialists, P.A.
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
Elizabeth : Ellioth Fishkin, MD
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Englewood : Drs. Forte, Schleider, Attas & Condemi, PA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
View More »
Hackensack : Hackensack University Medical Center
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Hackensack : Hackensack University Medical Center
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Hackensack : Hackensack University Medical Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Hackensack : Hackensack University Medical Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Hackensack :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Hackensack : John Theurer Cancer Center at the Hackensack University Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Hackensack :
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma
Hackensack : Pfizer Investigational Site
A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Hackensack : Hackensack University Medical Center
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Hackensack : Research Site
AMG 319 Lymphoid Malignancy FIH
Hackensack : Hackensack University Medical Center
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Hackensack : Hackensack University Medical Center Dept.of HackensackUniv.MedCtr.
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Hackensack : The Cancer Center at Hackensack University Medical Center
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Hackensack : Hackensack University Medical Center
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Hackensack : Hackensack University Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Hackensack : John Theurer Cancer Center at HackensackUMC
Phase II Clinical Protocol for the Treatment of Patients With Previously Untreated CLL With Four or Six Cycles of Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide Followed by Lenalidomide Consolidation/ Maintenance
Hackensack : John Theurer Cancer Center, Site #128 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Hackensack : Hackensack University Medical Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Hackensack : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Hackensack : John Theurer Cancer Center
Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy
Hackensack : John Theurer Cancer Center at Hackensack University Medical Center
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Hackensack : Hackensack University Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Morristown : Hematology Oncology Associates of Northern New Jersey
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Morristown : Hematology Oncology Associates of Northern New Jersey
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Morristown : Hematology Oncology Associates of Northern New Jersey
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Morristown : Hematology Oncology Associates of Northern New Jersey PA Dept of Hem-Onc of Northern NJ
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
Morristown : Charles Farber, MD
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Morristown : Hematology Oncology of Northern New Jersey
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Morristown : Goryeb Children'S Hospital
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Morristown : Hematology-Oncology Associates of Northern NJ, PA
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New Brunswick : UMDNJ/Robert Wood Johnson
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
New Brunswick : Investigational Site Number 840001
Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia
Paterson : St. Joseph'S Regional Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Somerville : Steeplechase Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Somerville : Somerset Hematology Oncology Associates
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Summit : Overlook Hospital
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Vineland : Southern Oncology Hematology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New York
Albany : New York Oncology Hematology, P.C.
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Albany : Samuel S Stratton VAMC
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Bay Shore : Hematology Oncology Associates of Western Suffolk
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Bronx : Children's Hospital at Montefiore
A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer
Bronx : Montifiore Medical Center
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
View More »
Bronx : Bronx River Medical Associates
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Bronx : Eastchester Center for Cancer Care
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Bronx : Albert Einstein College of Medicine
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Bronx : Montefiore Medical Center
Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia
Bronx : Montefiore Medical Center / AECOM
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Bronxville : Eduardo Saponara, MD
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Buffalo : Roswell Park Cancer Institute
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Buffalo : Roswell Park Cancer Institute
A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia
Buffalo :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Buffalo : Roswell Park Cancer Streets
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Buffalo : Jonah Cancer Care Center & ECMC
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Buffalo : Roswell Park Cancer Institiute
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Buffalo : Roswell Park Cancer Institute
Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)
Buffalo : Roswell Park Cancer Institute
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Buffalo : Roswell Park Cancer Institute
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Buffalo : Roswell Park Cancer Institute
Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia
Dunkirk :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Hawthorne : Westchester Hematology Oncology Group, PC
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Hawthorne : New York Medical College
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Johnson City : Broome Oncology
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Johnson City : Broome Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Lake Success : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Lake Success : North Shore - LIJ Health System
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Lake Success : North Shore Long Island Jewish Health System
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Mount Kisco : Westchester Hematology Oncology Associates
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
New Hyde Park : Long Island Jewish Medical Center
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
New Hyde Park : Site Reference ID/Investigator# 71813
A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed or Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
New Hyde Park : CLL Research and Treatment Program
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
New Hyde Park : North Shore University Hospital
A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
New Hyde Park : Long Island Jewish Medical Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
New Hyde Park : Long Island Jewish Medical Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
New Hyde Park : Long Island Jewish Medical Center
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
New Hyde Park : Long Island Jewish medical Center
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
New Hyde Park :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
New Hyde Park : Long Island Jewish Medical Center
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
New Hyde Park : Long Island Jewish Medical Center
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
New York : Memorial Sloan Kettering Cancer Center
A First-in-Human Phase 1 and Expanded Cohort Study of EPZ-5676 in Advanced Hematologic Malignancies, Including Acute Leukemia With Rearrangement of the MLL Gene
New York : Weill Cornell Medical College
A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)
New York : Site Reference ID/Investigator# 56810
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
New York : New York Presbyterian Hospital/ Cornell Medical Center
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
New York : Stephen D. Hassenfeld Children'S Center
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
New York : Weill Cornell Medical College
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
New York : Memorial Sloan Kettering Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
New York : Mount Sinai Medical Center
A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
New York : Weill Cornell Medical College
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
New York : Memorial Sloan Kettering Cancer Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
New York : Beth Israel Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
New York : Memorial-Sloan Kettering Cancer Center
A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)
New York : Memorial Sloan Kettering Cancer Center
Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
New York : Columbia Presbyterian Medical Center
Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL
New York : Weill Cornell Medical College
Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (THRiL) as Initial Treatment for Patients With CLL
New York : Memorial Sloan-Kettering Cancer Center
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
New York : Weill Medical College of Cornell
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
New York : Memorial Sloan-Kettering Cancer Center
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
New York : 1315.1.1002 Boehringer Ingelheim Investigational Site
BI 836858 Dose Escalation in Refractory or Relapsed Acute Myeloid Leukemia
New York : Weill Cornell Medical College
Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML)
New York : Mount Sinai School of Medicine & Mount Sinai Graduate School of biological Sciences
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
New York : Weill Cornell Medical College
Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)
New York : Columbia University Medical Center
Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL
New York : Columbia Presbyterian - Harlem
KW 0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
New York : Columbia University Medical Center
Lenalidomide in HTLV-1 Adult T-Cell Leukemia
New York : Memorial Sloan-Kettering Cancer Center
Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age
New York : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
New York : Memorial Sloan-Kettering Cancer Center
Palifermin With or Without Leuprolide Acetate Versus Control for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
New York : New York Presby Hospital, Weill Medical College at Cornell University
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
New York : Weill Cornell Medical College
Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
New York : Memorial Sloan-Kettering Cancer Center
Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome
New York : Mount Sinai Medical Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
New York : Weill Cornell Medical College
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
New York : Memorial Sloan Kettering Cancer Ctr
Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy
New York : Cornell University
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
New York : Memorial Sloan Kettering Cancer Center
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)
New York : Memorial Sloan-Kettering Cancer Center
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
New York : Weill Cornell Medical College
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
New York : Memorial Sloan Kettering Cancer Center
Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
New York : Weill Medical College of Cornell
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
New York : Advanced Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New York : St. Lukes Roosevelt Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New York : Memorial Sloan Kettering Cancer Center
Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies
New York : Children's Hospital New York-Presbyterian
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
New York City : Columbia Presbyterian Medical Center
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
New York City : New York Hospital Weill Cornell Medical Center
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
Rochester : Univ. of Rochester Cancer Center
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Rochester : University of Rochester Medical Center
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Rochester : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Stony Brook : Stony Brook University Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Stony Brook : Research Site
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders
Stony Brook : Stony Brook University Medical Center
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Stony Brook : Stony Brook University Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Syracuse : SUNY Upstate Medical University
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Syracuse : SUNY Upstate Medical University - Adult Program
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Syracuse : Suny Upstate Medical University
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Syracuse : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Valhalla : Investigational Site Number 840009
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Valhalla :
A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
Valhalla : New York Medical College
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Valhalla : New York Medical College, Division of Oncology
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Valhalla : New York Medical College, Division of Oncology/Hematology
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
North Carolina
Cary : US Oncology - Cancer Centers of North Carolina - Cary
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Cary : Waverly Hematology Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Chapel Hill : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Chapel Hill : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Chapel Hill : University of North Carolina Hospitals
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
View More »
Charlotte : Levine Children's Hospital
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Charlotte :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Charlotte : Levine Children'S Hospital
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Charlotte : Mecklenburg Medical Group
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Charlotte : Levine Children's Hospital at Carolinas Medical Center
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Durham : Site Reference ID/Investigator# 71393
A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed or Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Durham : Duke University Medical Center
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Durham : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Acute Leukemia
Durham : Duke University Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Durham : Research Site
AMG 319 Lymphoid Malignancy FIH
Durham : Duke University Medical Center
Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)
Durham : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Durham : Duke University
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Durham : Duke University Medical Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Durham : Duke University Medical Center
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Durham : Duke University Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Gastonia : Gaston Hematology Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Greenville : East Carolina University
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New Bern : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Raleigh : Cancer Centers of North Carolina Cancer Centers of NC-Raleigh
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
Raleigh : US Oncology - Cancer Centers of North Carolina - Macon
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Raleigh : US Oncology - Cancer Centers of North Carolina - Falls
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Raleigh : Rex Cancer Center
Telemonitoring Study - for Chronic Myeloid Leukemia (CML)
Raleigh : Rex Cancer Center - Wakefield
Telemonitoring Study - for Chronic Myeloid Leukemia (CML)
Winston-Salem : Wake Forest University
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Winston-Salem : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Winston-Salem : Wake Forest University Health Sciences
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
North Dakota
Bismarck :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Bismarck : Legacy Pharma Research
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Bismarck : Mid Dakota Clinic/Odyssey Research
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Fargo : Roger Maris Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Ohio
Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
A Feasibility Pilot and Phase 2 Study of Chemoimmunotherapy with Epratuzumab for Children with Relapsed CD22-Positive Acute Lymphoblastic Leukemia
Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
ADVL0816: A Phase I Study of Obatoclax (Pan Anti-Apoptotic BCL-2 Family Small Molecule Inhibitor), in Combination with Vincristine/Doxorubicin/Dexrazoxane, in Children with Relapsed/Refractory Solid Tumors or Leukemia
View More »
Akron : Summa Health System - Cancer Research Office
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Akron : Summa Health System Hospitals
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Akron : Akron General Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Canton : Call for Information (Investigational Site 0035)
A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714 AM2)
Canton : Investigational Site Number 840014
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Canton : Gabrail Cancer Center Research
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Canton : Gabrail Cancer Center
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Canton : Gabrail Cancer Center Research
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Canton : Nashat Y. Gabrail, MD, Inc.
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Canton : Gabrail Cancer Center
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Cincinnati : Cincinnati Children's Hospital Medical Center Cincinnati Children's Hosp
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Cincinnati : The Christ Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Cincinnati : Cincinnati Children'S Hospital Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Cleveland : Cleveland Clinic
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Cleveland : Cleveland Clinic Foundation
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Cleveland : Case Western Reserve University Hospitals of Cleveland
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Cleveland : University Hospitals Case Medical Center
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Cleveland : Cleveland Clinic
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Cleveland : Cleveland Clinic Taussig Cancer Center
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
Cleveland : Cleveland Clinic
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Cleveland : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Cleveland : Case Western Reserve University, University Hospitals of Cleveland
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Cleveland : Cleveland Clinic, Taussig Cancer Institute
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Cleveland : Cleveland Clinic
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Cleveland : University Hospitals Case Medical Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Cleveland : Pfizer Investigational Site
Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia
Cleveland : Research Site
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders
Cleveland : University Hospitals fo Cleveland
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Cleveland : University Hospitals Case Medical Center
Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission
Columbus : The Ohio State University
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Columbus : The Ohio State University Comprehensive Cancer Center
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Columbus : James Cancer Hospital
Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
Columbus : The Ohio State University Medical Center
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Columbus : 1315.1.1001 Boehringer Ingelheim Investigational Site
BI 836858 Dose Escalation in Refractory or Relapsed Acute Myeloid Leukemia
Columbus : Ohio State University Medical Center
Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
Columbus : The Ohio State University Medical Center
Bortezomib and Midostaurin With or Without Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Columbus : Mid Ohio Oncology / Hematology, Inc.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Columbus :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Columbus : Nationwide Children'S Hospital
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Columbus : For additional information regarding sites for this trial call (919) 465-4648
Phase 1b Safety and Efficacy Study of TRU-016 and Rituximab in Previously Untreated Chronic Lymphocytic Leukemia
Columbus : Ohio State Comprehensive Cancer Center/James Cancer Hospital Dept.ofJamesCancerHospital
Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
Columbus : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Columbus : Ohio State University
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Columbus : Ohio State University Medical Center
Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)
Columbus : Nationwide Childrens Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Dayton : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Dayton : The Children'S Medical Center Of Dayton
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Elyria : Hematology Oncology Center, Inc.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Middletown : Signal Point Clinical Research Center, Site #139 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Middletown : Signal Point Clinical Research Center, LLC
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Newark : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Newark : Medical Center of Newark
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Toledo : Mercy Children'S Hospital
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Oklahoma
Oklahoma City : University Of Oklahoma Health Sciences Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Oklahoma City : University of Oklahoma Health Science Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Oklahoma City : University of Oklahoma Health Sciences Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Tulsa : Cancer Care Associates
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Oregon
Eugene : Willamette Valley Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Eugene : Willamette Valley Cancer and Research / USOR
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Eugene : US Oncology - Willamette Valley Cancer Institute - Eugene
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Portland : Oregon Health & Sciences University
A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Portland : Oregon Health & Sci Univ
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
View More »
Portland : Northwest Cancer Specialists, PC
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Portland : Oregon Health and Science University
A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia
Portland : Oregon Health & Sciences
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Portland :
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma
Portland : Northwest Cancer Specialists Salmon Creek Office
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
Portland : Oregon Health Sciences University
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
Portland : Oregon Health & Science University
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Barnes
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Broadway
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Hoyt
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Portland : Oregon Health & Science University Dept. Hematologic Malignancies
Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy
Portland : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Portland : Legacy Emanuel Hospital & Health Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Portland : Oregon Health & Science University
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Portland : Oregon Health & Science University
Validation of an in Vitro Assay to Predict Targeted Therapies for Acute Leukemia Patients
Salem : Hematology/Oncology Salem LLP
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Springfield : Willamette Valley Cancer Center
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Springfield : Willamette Valley Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Springfield : Willamette Valley Cancer Institute and Research Center
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Springfield : US Oncology - Willamette Valley Cancer Institute - Springfield
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Springfield : US Oncology Research: Willamette Valley Cancer Institute and Research Center
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Springfield : Willamette Valley Cancer Institute and Research Center
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Tualatin : Northwest Cancer Specialists, PC
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Tualatin : Northwest Cancer Specialists, PC
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Tualatin : Northwest Cancer Specialists, P.C.
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Tualatin : US Oncology - Northwest Cancer Specialists, PC - Tualatin
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Pennsylvania
Bethlehem : Oncology Hematology of Lehigh Valley
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Danville : Geisinger Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Drexel Hill : Consultants in Medical Oncology and Hematology, PC
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Gettysburg : Gettysburg Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Harrisburg : Andrews and Patel Associates
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
View More »
Hershey : Penn State Milton S. Hershey Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Hershey : Penn State Milton S. Hershey Medical Center
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Hershey : Penn State Milton S. Hershey Medical Center
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Hershey : Penn State Hershey Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Hershey : Penn State Hershey Cancer Institute
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Kingston : US Oncology - Medical Oncology Associates (Nahar)
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Kingston : Medical Oncology Associates of Wyoming Valley, PC
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Lancaster : Lancaster Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Lancaster : Lancaster General Health
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Norristown : Luitpold Pharmaceuticals, Inc.
Bioequivalence Trial of Luitpold Azacitidine Versus Vidaza® in Patients With Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia or Chronic Lymphocytic Leukemia
Philadelphia : Children's Hospital of Philadelphia Pediatric Oncology Clinic
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Philadelphia : University of Pennsylvania, Abramson Cancer Center
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Philadelphia : Children'S Hospital Of Philadelphia
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Philadelphia : Fox Chase Cancer Center
A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
Philadelphia : Investigational Site Number 840001
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Philadelphia : Abramson Cancer Center of the University of Pennsylvania
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Philadelphia :
A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
Philadelphia : Hospital of the University of Pennsylvania
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Philadelphia : Thomas Jefferson University
Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma
Philadelphia : Hospital of the University of Pennsylvania
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Philadelphia : Thomas Jefferson University
Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)
Philadelphia : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Philadelphia : Children'S Hospital Of Philadelphia
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Philadelphia : University of Pennsylvania, Abramson Cancer Center
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Philadelphia : University of Pennsylvania Health System
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Philadelphia : Temple University at Jeanes Hospital
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)
Philadelphia : Hospital of the University of Pennsylvania
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)
Philadelphia : Abramson Cancer Center of the University at Perlman Center for Advanced Medicine
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Philadelphia : Thomas Jefferson University
Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias
Philadelphia : Abramson Cancer Center of the University of Pennsylvania
Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission
Pittsburgh : Western Pennsylvania Hospital
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Pittsburgh : Children'S Hospital Of Pittsburgh
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Pittsburgh : (160) The Western Pennsylvania Hospital- Cancer Institute
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
Pittsburgh : Children's Hospital of Pittsburgh
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Pittsburgh : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Pittsburgh : Children'S Hospital Of Pittsburgh Of Upmc
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Pittsburgh : The Western Pennsylvania Hospital
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Pittsburgh : Veterans Research Foundation of Pittsburgh
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Pottstown : Pottstown Memorial Medical Center
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Reading : Berks Hematology Oncology Associates
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Sayre : Call for Information (Investigational Site 0048)
A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714 AM2)
West Reading : Berks Hematology-Oncology Associates
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Wilkes Barre : Geisinger Health System
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Willow Grove : Abington Hematology Oncology Associates
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
York : Cancer Care Association Of York
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Rhode Island
Cranston : Hematology & Oncology Associates of Rhode Island
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Cranston : Sambandam and Joseph Associates, Inc
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Cranston : Hematology and Oncology Associates of RI
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
South Carolina
Charleston : Charleston Hematology Oncology
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Charleston : Medical University of South Carolina, Hollings Cancer Center
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Charleston : Charleston Hematology Oncology Associates, PA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Charleston : Charleston Hematology Oncology, PA
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Charleston : Medical University of South Carolina
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
View More »
Charleston : Medical University of South Carolina MUSC/HCC (2)
Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
Charleston : Investigational Site Number 840002
Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia
Charleston : Charleston Hematology and Oncology
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Charleston : Medical University of South Carolina
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Charleston : Charleston Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Charleston : Medical University of South Carolina
Trial of Intracycle Sequential Ofatumumab and Lenalidomide for the Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab
Columbia : Liberty Hematology Oncology
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Columbia : South Carolina Oncololgy Associates, PA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Columbia : South Carolina Oncology Associates
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Easley : US Oncology - Cancer Centers of the Carolinas - Easley
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Greenville : Cancer Centers of the Carolinas
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Greenville : Cancer Centers of the Carolinas CCC Greenville
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Greenville : Cancer Centers of the Carolinas
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Greenville : Saint Francis Hospital
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Greenville : US Oncology - Cancer Centers of the Carlinas - Eastside
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Greenville : US Oncology - Cancer Centers of the Carolinas - Butternut
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Greenville : US Oncology - Cancer Centers of the Carolinas - West Faris
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Greenville : Bon Secours St. Francois Health System
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Greenville : Greenville Hospital System
Trial of Intracycle Sequential Ofatumumab and Lenalidomide for the Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab
Hilton Head Island : South Carolina Cancer Specialists
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Seneca : US Oncology - Cancer Centers of the Carolinas - Seneca
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Spartanburg : US Oncology - Cancer Centers of the Carolinas - Spartanburg
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Sumter : Carolina Hematology Oncology, Site #143 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
South Dakota
Sioux Falls : (120) Avera Cancer Institute
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
Sioux Falls : Sanford Clinic
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Watertown : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Watertown : Prairie Lakes Healthcare System, Inc
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Tennessee
Bartlett : US Oncology - University of Tennessee Cancer Institute - Bartlett
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Collierville : Family Cancer Center, PLLC
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Collierville : The Family Cancer Center
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Germantown : The Jones Clinic
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
Germantown : US Oncology - University of Tennessee Cancer Institute - Germantown
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
View More »
Germantown : C. Michael Jones, MD, PC
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Knoxville : East Tennessee Children'S Hosp
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Knoxville : Tennessee Cancer Specialists
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Memphis : Research Site
CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Memphis : St. Jude Children's Research Hospital
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Memphis : US Oncology - University of Tennessee Cancer Institute - Memphis
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Memphis : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Memphis : Family Cancer Center
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Memphis : St. Jude
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Nashville : Sarah Cannon Cancer Center
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Nashville : Vanderbilt-Ingram
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Nashville : Sarah Cannon Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Nashville : Sarah Cannon Research Institute
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Nashville :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Nashville : Vanderbilt University Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Nashville : Sarah Cannon Research Institute
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Nashville : Tennessee Oncology Dept. of Centennial Medical
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Nashville : SCRI
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Nashville : Vanderbilt U Medical Center
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Nashville : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Nashville : Vanderbuilt University
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Nashville : SCRI
Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)
Nashville : Tennessee Oncology, Pllc
Phase IIb Study of Dasatinib Versus Imatinib in Patients With CML-CP Who Have Not Achieved an Early Optimal Response to Imatinib
Nashville : Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt 3
Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
Nashville : Henry-Joyce Cancer Clinic
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Nashville : Tennessee Oncology, PLLC
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Nashville : Sarah Cannon Research Institute
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Nashville : Vanderbilt University
Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission
Nashville : Vanderbilt Children's Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Texas
Abilene : US Oncology - Texas Cancer Center - Abilene (South)
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Amarillo : US Oncology - Texas Oncology, PA - Amarillo
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Amarillo : Texas Oncology
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
Amarillo : Texas Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Arlington : US Oncology - Texas Oncology - Arlington South
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
View More »
Arlington : Texas Oncology - Arlington South
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Austin : Texas Oncology
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Austin : Dell Children'S Medical Center Of Central Texas
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Austin : US Oncology - Texas Oncology Austin, Site #172 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Austin : Texas Oncology-Austin North
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Beaumont : Julie & Ben Rogers Cancer Institute
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Bedford : Texas Oncology, P.A.
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
Bedford : US Oncology - Texas Oncology, PA - Bedford
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Bryan : St. Joseph Regional Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
College Station : Scott & White Clinic
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Corpus Christi : South Texas Institute of Cancer
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Corpus Christi : Coastal Bend Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Corpus Christi : Driscoll Children'S Hospital
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Dallas : Texas Oncology PA
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Dallas : (105) University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
Dallas : Baylor Charles A. Sammons Cancer Center at Dallas
A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Dallas : Mary Crowley Cancer Research Centers - Medical City
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Dallas : Baylor University Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Dallas : UT Southwestern Medical Center
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Dallas : Presbyterian Hospital of Dallas TexasOncology@PresbyterianHosp
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
Dallas : Texas Oncology, P.A. Texas Oncology - Sugar Land
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
Dallas : Texas Oncology - Dallas Presbyterian
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Dallas : Texas Oncology - Medical City Dallas
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Dallas : US Oncology - Texas Oncology, PA - Dallas
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Dallas :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Dallas : Ut Southwestern
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Dallas : University of Texas Southwestern Medical Center
Phase II Study of Crenolanib in Subjects With Relapsed AML With FLT3-D835 Activating Mutations
Dallas : US Oncology - Texas Oncology Dallas, Site #171 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Dallas : University of Texas Southwestern Medical Center at Dallas
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Dallas : University of Texas Southwestern Medical Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Dallas : UT Southwestern Medical Center at Dallas
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Dallas : Texas Oncology-Methodist Charlton Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Dallas : Texas Oncology-Dallas Presbyterian Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Dallas : Texas Oncology-Medical City Dallas
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
El Paso : US Oncology - El Paso Cancer Treatment Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
El Paso : US Oncology - El Paso Cancer Treatment Center - West
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Fort Worth : Texas Oncology, P.A.
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Fort Worth : Texas Oncology, P.A.
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Fort Worth : Texas Oncology, P.A.
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Fort Worth : Texas Oncology - Fort Worth 12th Avenue
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Fort Worth : Cook's Children's Medical Center
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Fort Worth : US Oncology - Texas Oncology, PA - Fort Worth
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Fort Worth : US Oncology - Southwest Fort Worth Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Fort Worth : JPS Center for Cancer Care
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Fort Worth : Cook Children'S Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Grapevine : US Oncology - Texas Oncology - Grapevine
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Houston : UT MD Anderson Cancer Center
2CDA With Rituximab in Hairy Cell Leukemia
Houston : UT MD Anderson Cancer Center
5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Houston : Site Reference ID/Investigator# 48326
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
Houston : MD Anderson Cancer Center
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Houston : MD Anderson Cancer Center
A Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients With FLT3 Activating Mutations
Houston : Md Anderson Cancer Center
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Houston : Texas Children'S Cancer Center
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Houston : M.D. Anderson Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Houston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Acute Leukemia
Houston : M.D. Anderson Cancer Center
A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)
Houston : MD Anderson Cancer Center
A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
Houston : Texas Children's Hospital
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Houston :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Houston : Pfizer Investigational Site
A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia
Houston : MD Anderson Cancer Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Houston : M.D. Anderson Cancer Center
A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)
Houston : Site Reference ID/Investigator# 26522
ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies
Houston : UT MD Anderson Cancer Center
Acute Promyelocytic Leukemia (APL) Treated With ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin
Houston : MD Anderson Cancer Center
A-dmDT390-bisFv (UCHT1) Immunotoxin Therapy for Patients With T-cell Diseases
Houston : MD Anderson Cancer Center
ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia
Houston : MD Anderson Cancer Center/University of Texas
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
Houston : Baylor College of Medicine Baylor College of Medicine (3)
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
Houston : MD Anderson Cancer Center
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Houston : MD Anderson Cancer and Research Center
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Houston :
An Extension Study of RO5045337 in Patients Participating in Previous Cancer Studies
Houston : MD Anderson
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Houston : UT MD Anderson Cancer Center
Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)
Houston : MD Anderson Cancer Center / University of Texas
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Houston : M D Anderson Cancer Center
Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
Houston : University of Texas MD Anderson Cancer Center
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Houston : UT MD Anderson Cancer Center
CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies
Houston : UT MD Anderson Cancer Center
Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)
Houston : UT MD Anderson Cancer Center
Combination Study of Cytarabine and Tosedostat in Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndromes (MDS)
Houston : Oncology Consultants
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Houston : MD Anderson Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Houston : The University Of Texas - M.D. Anderson Cancer Center
Dasatinib Combo With SMO Inhibitor (BMS-833923)
Houston : The University of Texas MD Anderson Cancer Center
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Houston : UT MD Anderson Cancer Center
Eltrombopag for Management of Thrombocytopenia
Houston : University of Texas MD Anderson Cancer Center
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Houston : UT MD Anderson Cancer Center
Fludarabine, Bendamustine and Rituximab Conditioning for Patients With Lymphoid Malignancies
Houston : UT MD Anderson Cancer Center
Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations
Houston : UT MD Anderson Cancer Center
Hyper CVAD Plus Ofatumumab in CD - 20 Positive Acute Lymphoblastic Leukemia (ALL)
Houston : UT MD Anderson Cancer Center
Hyper-CVAD and Ponatinib in Ph-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL)
Houston : UT MD Anderson Cancer Center
Inotuzumab Ozogamycin in Elderly Acute Lymphoblastic Leukemia (ALL)
Houston : UT MD Anderson Cancer Center
Low Dose Cytarabine and Lintuzumab-Ac225 in Older Patients
Houston : M. D. Anderson Cancer Center at University of Texas
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Houston : MD Anderson Cancer Center/University of Texas UT MD Anderson
Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy
Houston : UT MD Anderson Cancer Center
Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)
Houston : U.T. M.D. Anderson Cancer Center
Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy
Houston : UT MD Anderson Cancer Center
Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
Houston : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Houston : Baylor College Of Med/Tx Chldrns Cancer & Hem Ctrs.
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Houston : UT MD Anderson Cancer Center
Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies
Houston : The University of Texas MD Anderson Cancer Center
Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients
Houston : UT MD Anderson Cancer Center
Phase I/II - Dasatinib and Decitabine
Houston : MD Anderson Cancer Center
Phase I/II Study of DFP-10917 in Patients With Acute Leukemia
Houston : UT MD Anderson Cancer Center
Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)
Houston : UT MD Anderson Cancer Center
Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML)
Houston : The University of Texas M.D. Anderson Cancer Center
Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Houston : UT MD Anderson Cancer Center
Phase II Study of Ofatumumab in Elderly Patients With Chronic Lymphocytic Leukemia (CLL)
Houston : UT MD Anderson Cancer Center
Pilot Study to Determine Effects of the Btk Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With CLL and SLL
Houston : UT MD Anderson Cancer Center
PKC412 and 5-Azacytidine
Houston : UT MD Anderson Cancer Center
Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)
Houston : UT MD Anderson Cancer Center
Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)
Houston : UT MD Anderson Cancer Center
RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia
Houston : University of Texas M. D. Anderson Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Houston : UT MD Anderson Cancer Center
Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2
Houston : University of Texas M.D. Anderson Cancer Center
Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies
Houston : Research Site
Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients
Houston : UT MD Anderson Cancer Center
Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL
Houston : UT MD Anderson Cancer Center
Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
Houston : Investigational Site Number 840001
SAR3419 in Acute Lymphoblastic Leukemia
Houston : MD Anderson Cancer Center
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Houston : UT MD Anderson Cancer Center
Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome
Houston : Investigational Site Number 840003
Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia
Houston : Research Site
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders
Houston : UT MD Anderson Cancer Center
Study of Dasatinib in Patients With Chronic Myelogenous Leukemia
Houston : University of Texas M.D. Anderson Cancer Center
Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias
Houston : MD Anderson Cancer Center
Study of KB004 in Subjects With Hematologic Malignancies
Houston : MD Anderson Cancer Center
Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia
Houston : Call for Information (Investigational Site 0002)
Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)
Houston : The University of Texas, M.D. Anderson Cancer Center, Department of Leukemia
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Houston : UT MD Anderson Cancer Center
Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias
Houston : The University Of Texas Md Anderson Cancer Center
Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Houston : MD Anderson Cancer
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Houston : Michael DeBakey VA Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Houston : MD Anderson Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Houston : University of Texas - MD Anderson Cancer Center
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Houston : MD Anderson Cancer Center
TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation
Houston : UT MD Anderson Cancer
Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Houston, : M.D. Anderson Cancer Center
Clinical Study of PM01183 in Patients With Acute Leukemia
Houston, Texas : The University of Texas, M.D. Anderson Cancer Center
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Kerrville : US Oncology - San Antonio Tumor & Blood Clinic - Kerrville
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Lackland AFB : Wilford Hall Medical Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Laredo : South Texas Research Alliance, LLC
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Lewisville : Texas Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Longview : US Oncology - Longview Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Lubbock : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Lubbock : Joe Arrington Cancer Research and Treatment Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Lubbock : Joe Arrington Cancer Research and Treatment Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
McAllen : US Oncology - Texas Oncology - McAllen
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
McAllen : Texas Oncology-McAllen South Second
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Mesquite : US Oncology - Texas Oncology - Mesquite
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Mesquite : Texas Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Midland : US Oncology - Allison Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Midland : US Oncology - Texas Oncology Midland, Site #173 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Midland : Texas Oncology-Midland Allison Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Odessa : Texas Oncology-Odessa West Texas Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Paris : US Oncology - Texas Oncology - Paris
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Paris : Texas Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Plano : North Texas Regional Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Round Rock : Texas Oncology - Central Austin Cancer Center
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
San Antonio : Cancer Care Network of South Texas
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
San Antonio : Cancer Care Centers of South Texas
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
San Antonio : Cancer Care Network of South Texas
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
San Antonio :
A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
San Antonio : Cancer Care Centers of South Texas / HOAST CCC of So. TX- San Antonio(2)
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
San Antonio : US Oncology - Cancer Care Centers of South Texas
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
San Antonio : US Oncology - San Antonio Tumor & Blood Clinic - M. Oak
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
San Antonio : University of Texas Health Science Center, San Antonio
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
San Antonio : US Oncology - Cancer Care Center of South Texas, Site #170 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
San Antonio : Cancer Care Centers of South Texas
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
San Antonio : Cancer Therapy Reasearch Center at UTHSCA
Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
San Antonio : Texas Transplant Physician's Group
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
San Antonio : Cancer Care Centers of South Texas
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
San Antonio : Cancer Care Centers of South Texas
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Sherman : US Oncology - Texas Oncology - Sherman
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Temple : Scott and White Hospital and Clinic
A-dmDT390-bisFv (UCHT1) Immunotoxin Therapy for Patients With T-cell Diseases
Temple : Scott & White Healthcare Department of Research
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Temple : Scott & White Healthcare
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Temple : Central Texas Veterans Health Care System
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Tyler : ETMC dba Blood and Cancer Center - East Texas
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Tyler : US Oncology - Texas Oncology - Tyler
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Tyler : ETMC dba Tyler Hematology Oncology
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Waco : US Oncology - Texas Oncology Cancer Care and Research Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Waco : Texas Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Weslaco : US Oncology - Texas Oncology - Weslaco
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Wichita Falls : US Oncology - Texoma Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Utah
American Fork : Central Utah Clinic
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Logan : Cache Valley Cancer Treatment & Research Clinic, Inc.
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Ogden : Northern Utah Associates
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Salt Lake City : University of Utah
A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia
Salt Lake City : Huntsman Cancer Institute at the University of Utah
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
View More »
Salt Lake City : University of Utah, Huntsman Cancer Institute
Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients
Salt Lake City :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Salt Lake City : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Salt Lake City : Huntsman Cancer Institute, Site #043 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Virginia
Abingdon : Cancer Outreach Associates, PC
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Arlington : US Oncology - Arlington Fairfax Hematology Oncology
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Charlottesville : Virginia University
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Charlottesville : University of Virginia Health System
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Christianburg : Oncology and Hematology Assoc of SW VA DBA Blue Ridge Cancer Care
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
View More »
Christiansburg : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Christiansburg
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Fairfax : Virginia Cancer Specialists, PC
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Fairfax : Virginia Cancer Specialists, PC
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Fairfax : Virginia Cancer Specialists, PC
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Fairfax : US Oncology - Fairfax Northern VA Hem-Onc PC
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Falls Church : Inova Fairfax Medical Center
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Fredericksburg : Hematology Oncology Associates of Fredricksburg
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Gainesville : US Oncology - Fairfax - Northern Virginia Hematology-Oncology, PC - Gainesville
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Leesburg : US Oncology - Fairfax - Northern Virginia Hem-Onc, PC - Leesburg
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Low Moor : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Low Moor
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Newport News : Peninsula Cancer Institute
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Norfolk : Children'S Hosp-Kings Daughter
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Richlands : Virginia Oncology Care, PC
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Richmond : Massey Cancer Center/Virginia Commonwealth University
Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
Roanoke : Oncology and Hematology Associates of Southwest Virginia, Inc.
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Roanoke : Oncology and Hematology Associates of Southwest Virginia, Inc
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Roanoke : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Roanoke
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Roanoke : Blue Ridge Cancer Care
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Salem : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Salem
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Winchester : US Oncology - Shenandoah Oncology - Winchester
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Woodbridge : US Oncology - Fairfax - Northern Virginia Hem-Onc, PC - Woodbridge
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Wytheville : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Wytheville
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Washington
Bellingham : Peace Health Medical Group
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Edmonds : Puget Sound Cancer Centers
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Edmonds : US Oncology - Puget Sound Cancer Center - Edmonds
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Everett : Providence Everett Medical Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Kennewick : Columbia Basin Hematology and Oncology
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
View More »
Seattle : Site Reference ID/Investigator# 52882
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
Seattle : Fred Hutchinson Cancer Research Center
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Seattle : Seattle Cancer Care Alliance
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Seattle : Seattle Children'S
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Seattle : Seattle Cancer Care Alliance
A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)
Seattle : Fred Hutchinson Cancer Research Center
A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
Seattle :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Seattle : Seattle Children's Hospital CPKC412A2114
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
Seattle : US Oncology - Puget Sound Cancer Center - Seattle
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Seattle :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Seattle : Seattle Children's Hospital
Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL
Seattle : University Of Washington
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
Seattle : University of Washington
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Seattle : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Seattle : Fred Hutchinson Cancer Research Center
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Seattle : Fred Hutchinson Cancer Research Center
Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients
Seattle : Fred Hutchinson Cancer Research Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Seattle : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Seattle : Pfizer Investigational Site
Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia
Seattle : Seattle Cancer Care Alliance
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
Seattle : Swedish Tumor Institute-Medical Oncology
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Seattle : Fred Hutchinson Cancer Research Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Seattle : Seattle Children's Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Spokane : Cancer Care Northwest, US Oncology
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Spokane : US Oncology - Cancer Care Northwest - Holland
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Spokane : US Oncology - Cancer Care Northwest - Sherman
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Spokane : Medical Oncology Associates PS
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Spokane : US Oncology - Cancer Care Northwest - Mission
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Spokane : Providence Cancer Center at Sacred Heart Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Spokane Valley : Cancer Care Northwest
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Tacoma : Northwest Medical Specialties
A Randomized, Controlled Study Evaluating the Efficacy and Safety of GS-1101 (CAL-101) in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia
Vancouver : US Oncology - Northwest Cancer Specialists, PC - Vancouver - 136th St.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Vancouver : US Oncology - Northwest Cancer Specialists, PC - Vancouver - 134th St
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Vancouver : US Oncology - Northwest Cancer Specialists, Site #174 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Walla Walla : Providence St. Mary Regional Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Walla Walla : Providence St. Mary Regional Cancer Center
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Wenatchee : Wenatchee Valley Medical Center
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Wenatchee : Wenatchee Valley Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Yakima : Yakima Valley Memorial Hospital/North Star Lodge
A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Yakima : Yakima Valley Memorial Hospital
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Yakima : Yakima Valley Memorial Hospital / North Star Lodge
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Yakima : Yakima Regional Cancer Care
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Yakima : Yakima Valley Memorial Hospital / North Star Lodge
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Yakima : US Oncology - Yakima Valley Memorial Hospital/North Star Lodge (Boyd)
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Yakima : North Star Lodge Cancer Center
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Yakima : Yakima Valley Memorial Hospital/North Star Lodge
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
West Virginia
Morgantown : West Virginia University - Clinical Trials Research Unit
CASE 1908: A Phase I/II Study of Midostaruin(PKC412) and 5-Azaacitidine for Elderly Patients with Acute Myelogenous Leukemia
Morgantown : West Virginia University - Clinical Trials Research Unit
E2906- Phase III trial of Clofarabine as induction and post-remission therapy vs. standard daunorubicin & cytarabine post-remission therapy, followed by decitabine maintenance vs. observation in newly-diagnosed Acute Myeloid Leukemia in older adults (age greater than or equal to 60 years)
Morgantown : West Virginia University - Clinical Trials Research Unit
ECOG 10404: Randomizewd Ph2, Three Fludarabine/Antibody Combinations for patients with Symptomatic, Previously Untreated Chronic Lymphocytic Leukemia
Morgantown : West Virginia University - Clinical Trials Research Unit
S0535 - A Phase II Study of ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin in Patients with Previously Untreated, High-Risk Acute Promyelocytic Leukemia
Morgantown : West Virginia University - Clinical Trials Research Unit
S0805 - Phase II Study of Combination of Hyper-CVAD and Dasatinib with or without allogeneic stem cell transplant in Patients with Philadelphia(Ph)Chromosome Postive and/or Bcr-Abl Positive Acute Lymphoblastic Leukemia(ALL)
View More »
Martinsburg : City Hospital - West Virginia University Hospital East
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Morgantown : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Morgantown : Investigational Site Number 840002
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Morgantown : West Virginia University Hospital
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
Morgantown : Department of Medicine Section of Hematology/Oncology, West Virginia University Hospitals, Mary Babb Randolph Cancer Center, West Virginia University
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Wheeling : Wheeling Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Wisconsin
Green Bay : St. Vincent Hospital/Green Bay Oncology
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Green Bay : St Vincent Hospital
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Green Bay : St Vincent Regional Cancer Center
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Green Bay : Bellin Memorial Hospital
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Janesville : Mercy Health System Heme/Onc
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
View More »
LaCrosse : Gundersen Clinic
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Madison : Site Reference ID/Investigator# 56811
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
Madison :
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma
Madison : University of Wisconsin
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Madison : Kenneth DeSantes., MD
Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors
Madison : University of Wisconsin Carbone Cancer Center
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Madison : University of Wisconsin
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
Marshfield : Marshfield Clinic
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Milwaukee : Children's Hospital of Wisconsin
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Milwaukee : The Medical College of Wisconsin
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Milwaukee : Medical College of Wisconsin
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Milwaukee : Medical College Of Wisconsin
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Milwaukee : Medical College of Wisconsin
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Milwaukee : Medical College of Wisconsin
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Oconomowoc : Oconomowoc Memorial Hospital
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Waukesha : Waukesha Memorial Hospital
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Waukesha : Waukesha Memorial Hospital
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Wausau : Aspirus Regional Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Wisconsin Rapids : Riverview Hospital
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Argentina
Buenos Aires :
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Buenos Aires : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Buenos Aires : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Buenos Aires : Novartis Investigative Site
Randomized ph Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib
Buenos Aires : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
View More »
Buenos aires : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Bunos Aires : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Capital Federal : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Ciudad Autonoma de Buenos Aires : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Ciudad Autonoma de Buenos Aires : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Cordoba : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Córdoba :
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Derqui, Pilar : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
El Palomar : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Rio Negro : Novartis Investigative Site
Randomized ph Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib
Rio Negro : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Australia
Adelaide : IMVS
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Adelaide : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Adelaide : Royal Adelaide Hospital
Study of KB004 in Subjects With Hematologic Malignancies
Adelaide : IMVS
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Adelaide : Flinders Medical Centre
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
View More »
Adelaide : Haematology and Bone Marrow Transplant Unit, Royal Adelaide Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Bedford Park : Flinders Medical Centre
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Brisbane :
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Camperdown : Royal Prince Alfred Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Clayton : Investigational Site Number 036002
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Clayton : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Concord : Concord Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Concord : Concord Repatriation General Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Darlinghurst : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
East Melbourne : Site Reference ID/Investigator# 48323
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
East Melbourne : Site Reference ID/Investigator# 70394
A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed or Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
East Melbourne : Peter MacCallum Cancer Centre
A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia
East Melbourne : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Fitzroy : St. Vincent's Hospital
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Fitzroy :
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Fitzroy : St. Vincent's Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Fitzroy : St. Vincent Hospital
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Footscray : The Western Hospital
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Frankston : Frankston Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Garran : The Canberra Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Geelong : Andrew Love Cancer Center, Geelong Hospital, Barwon Health
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Gosford : Haematology Department, Gosford Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Herston : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Herston : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Herston : Local Institution
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Herston, Brisbane : Royal Brisbane and Women's Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Hobart : Investigational Site Number 036001
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Kingswood : Nepean Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Kingswood : Nepean Cancer Care Centre
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Kogarah :
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Kogarah : The St. George Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Kurralta Park :
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Malvern : Cabrini Hospital
A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia
Melbourne :
A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia
Melbourne : Royal Melbourne Hospital
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Melbourne : The Alfred Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Nedlands : Sir Charles Gairdner Hospital
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Nedlands : Sir Charles Gairdner Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Nedlands : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
New Lambton Heights :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Newcastle : Calvary Mater Hospital
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
North Adelaide : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Northmead : Westmead Hospital
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Parkville : Site Reference ID/Investigator# 48322
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
Parkville : Site Reference ID/Investigator# 70393
A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed or Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Parkville : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Parkville : Royal Melbourne Hospital
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
Parkville :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Parkville : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Parkville : Department of Clinical Haematology and BMT Service, Royal Melbourne Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Perth : Investigational Site Number 036003
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Perth : Local Institution
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Perth : Royal Perth Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Prahran : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Prahran : The Alfred Hospital
Study of KB004 in Subjects With Hematologic Malignancies
Randwick : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Randwick : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
St. Leonards : Royal North Shore Hospital
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
St. Leonards : Royal North Shore Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
St. Leonards : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Sydney : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Westmead :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Westmead : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Westmead : Westmead Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Westmead, NSW : Children's Hospital at Westmead
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Woolloongabba : Princess Alexandra Hospital
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Woolloongabba : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Woolloongabba : Princess Alexandra Hospital
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Austria
Feldkirch : LKH Feldkirch, Interne E
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Feldkirch : LKH Feldkirch, Interne E
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Graz : 1102 - LKH Graz
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Graz : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Graz : Universitatsklinik Graz, Universitatsklinik fur Innere Medizin, Abteilung fur Hamatologie
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
View More »
Hall : A.ö. Bezirkskrankenhaus Hall in Tirol, Innere Medizin / Hämato - Onkologie
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Innsbruck : Novartis Investigative Site
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Innsbruck : Universitätsklinik für Innere Medizin Innsbruck, Klinische Abteilung für Hämatologie und Onkologie
Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL
Innsbruck : Universitätsklinik für Innere Medizin Innsbruck, Klinische Abteilung für Hämatologie und Onkologie
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Innsbruck : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Innsbruck : GSK Investigational Site
Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia
Innsbruck : Medizinische Universität Innsbruck
Protocol in Acute Myeloid Leukemia With FLT3-ITD
Innsbruck : Universitätsklinik Innsbruck, Innere MEdizin IV / Hämato-Onkologie
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Innsbruck : Innsbruck Medical University
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Innsbruck : University Hospital for Internal Medicine V, Innsbruck Medical University
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Krems : Landesklinikum Krems, Hämato-onkologisches Service
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Kufstein : A.ö. Bezirkskrankenhaus Kufstein, Innere Medizin / Hämatologie / Onkologie
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Linz : Krankenhaus der Barmherzigen
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Linz : 1107 - Krankenhaus der Elisabethinen
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Linz : Krankenhaus der Elisabethinen Linz GmbH, 1. Interne
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Linz : AKH Linz, Innere Medizin 3, Zentrum für Hämatologie und medizinische Onkologie
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Linz : Krankenhaus d. Barmherzigen Schwestern Linz, Interne I
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Linz : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Linz : GSK Investigational Site
Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia
Linz : Krankenhaus der Barmherzigen Schwestern Linz
Protocol in Acute Myeloid Leukemia With FLT3-ITD
Linz : Krankenhaus der Elisabethinen Linz GmbH
Protocol in Acute Myeloid Leukemia With FLT3-ITD
Linz : AKH Linz, Department für Innere Medizin 3
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Salzburg : Center for Clinical Cancer and Immunology Trials
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Salzburg : 1106
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Salzburg : Universitätsklinik der PMU Salzburg, Univ-Klinik für Innere Medizin III
Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL
Salzburg : Universitaetsklinik der PMU Salzburg, UK f. Innere Medizin III
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Salzburg : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Salzburg : GSK Investigational Site
Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia
Salzburg : Universitätsklinik für Innere Medizin III Salzburg
Protocol in Acute Myeloid Leukemia With FLT3-ITD
Salzburg : Universitätsklinik der PMU Salzburg, Univ-Klinik für Innere Medizin
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Salzburg : Landeskrankenhaus Salzburg, Universitaetsklinik fur innere Medizin lll, Universitaetsklinikum der PMU
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Steyr : Landeskrankenhaus Steyr, Innere Medizin, Hämatologie, Onkologie
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Vienna : Medical University of Viena
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Vienna : Novartis Investigative Site
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Vienna : St. Anna Kinderspital
Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Vienna : 1101 - AKH Wien
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Vienna : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Vienna : Medical University of Vienna
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Wels : Abteilung für Innere Medizin IV
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Wels : Klinikum Wels-Grieskirchen GmbH, IV. Interne Abteilung
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Wels : Klinikum Wels-Grieskirchen GmbH, Abteilung für Innere Medizin IV
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Wien : Wilhelminenspital
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Wien : Novartis Investigative Site
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
Wien : Hanusch Krankenhaus, 3. Med. Abtlg. Für Hämatologie und Onkologie
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Wien : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Wien : Hanuschkrankenhaus Wien
Protocol in Acute Myeloid Leukemia With FLT3-ITD
Wien : Hanusch Krankenhaus, 3. Med. Abtlg.
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Wien : AKH Wien, Klinische Abteilung für Hämatologie und Hämostaseologie
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Wien : AKH Wien / MedUniWien Universtatsklinik fur Innere Medizin 1
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Belgium
Antwerp : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Antwerp : Ziekenhuis Netwerk Antwerpen
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Antwerpen : Ziekenhuisnetwerk Antwerpen - AZ Stuivenberg
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Antwerpen : GSK Investigational Site
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Antwerpen : 1504
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
View More »
Antwerpen : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Antwerpen : ZNA Middleheim Lindendreef 1
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Antwerpen : ZNA Stuivenberg, Lange Beeldekensstraat 267
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Brasschaat : GSK Investigational Site
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Brugge : Novartis Investigative Site
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Brugge : GSK Investigational Site
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Brugge : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Brugge : AZ St.-Jan Brugge-Oostende AV
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Brügge : 1505
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Brussels : 1502 - Cliniques Universitaires de Saint-Luc
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Brussels : Institute Jules Bordet, Department of Hematology
NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)
Brussels : Cliniques universitaires Saint-Luc
NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)
Brussels : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Brussels : Institut Jules Bordet
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Brussels : CHU Erasme Clinic of Hematology
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Brussels : Cliniques Universitaires Saint Luc
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Bruxelles : Investigational Site Number 056003
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Bruxelles : Hopital Des Enfants Reine Fabiola
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Bruxelles : Hopital Saint Luc
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Bruxelles : 1270.1.32001 Boehringer Ingelheim Investigational Site
BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)
Bruxelles : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Gent : Investigational Site Number 056002
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Gent : UZ Gent
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Gent : 1270.1.32003 Boehringer Ingelheim Investigational Site
BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)
Gent : 1503
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Gent : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Gent : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Gent : Universitair Ziekenhuis Gent
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Godinne : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Haine Saint Paul : Hopital de Jolimont
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Haine-Saint Paul : Hopital de Jolimont
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Haine-saint-Paul : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Hasselt : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Kortrijk : AZ Groeninge
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Kortrijk : AZ Groeninge Kortrijk
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Leuven : Novartis Investigative Site
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Leuven : Investigational Site Number 056001
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Leuven : GSK Investigational Site
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Leuven : 1270.1.32002 Boehringer Ingelheim Investigational Site
BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)
Leuven : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Leuven : University Hospital Gasthuisberg, Department of Hematology
NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)
Leuven : UZ Gasthuisberg - Department of Hematology, Site #700 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Leuven : UZ Leuven
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Leuven : UZ Leuven, campus Gasthuisberg, Department of Haematology
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Liege : Chr de La Citadelle
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Liege : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Montegnee : Chc Esperance
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Montigny-Le Tilleul : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Roeselare : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Roeselare : H. Hartziekenhuis Roeselare-Menen vzw
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Roeselare : H.-Hartziekenhuis Roeselare - Menen vzw
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Turnhout : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Wilrijk : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Yvoir : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Yvoir : Novartis Investigative Site
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Yvoir : 1501 - Cliniques Universitaires UCL de Mont Godinne
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Yvoir : CHU de Mont-Godinne
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Yvoir : Clinique Universitaire de Mont Godinne
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Brazil
Barretos : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Barretos : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Barretos : Fundacao Pio XII - Hospital de Cancer de Barretos
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Belo Horizonte : BIOCANCER - Centro de Pesquisa e Tratamento do Câncer S/A
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Brasílía : Hospital Universitario de Brasilia
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
View More »
Curitiba : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Curitiba : Hospital Erasto Gaertner
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Goiania :
CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Goiania : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Jaú : Novartis Investigative Site
Randomized ph Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib
Londrina : Pro Onco Centro de Tratamento Oncológico
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Morumbi : Hospital Israelita Albert Einstein
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Porto Alegre : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Porto Alegre :
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Porto Alegre : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Porto Alegre : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Porto Alegre : Hospital Nossa Senhora da Conceição
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Porto Alegre : Hospital de Clínicas de Porto Alegre
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Rio de Janeiro : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Rio de Janeiro : Instituto Estadual Arthur de Siqueira Cavalcanti - HEMORIO
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Rio de Janeiro : Instituto Nacional Del Cancer
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Salvador : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Salvador : Monte Tabor Hospital Sao Rafael
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Santo Andre : Centro de Estudos e Pesquisas de Hematologia e Oncologia da
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Sao Paulo : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Sao Paulo : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Sao Paulo :
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Sao Paulo : Instituto de Ensino e Pesquisa São Lucas
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Sao Paulo : Fundacao Antonio Prudente - Hospital do Cancer AC Camargo
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
São Paulo : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
São Paulo : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Bulgaria
Pleven : Clinic of Hematology
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Plovdiv : Clinic of Hematology
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Sofia : GSK Investigational Site
Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia
Sofia : Military Medical Academy Clinic of Hematology and Oncology
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Varna : UMHAT Clinic of Hematology
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Canada
Calgary :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Calgary : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Calgary : Alberta Children's Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Edmonton : Novartis Investigative Site
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Edmonton : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
View More »
Edmonton :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Greenfield Park : Hopital Charles LeMoyne
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Greenfield Park : Charles LeMoyne Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Halifax : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Halifax :
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Halifax : CDHA Centre for Clinical Research
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Halifax : Queen Elizabeth II Health Sciences Centre
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Hamilton :
A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia
Hamilton : McMasters University Medical Center
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Hamilton : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Kirkland : Merck Frosst Canada Ltd.
Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)
Kitchener : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
London : Local Institution
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Montreal : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Montreal :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Montreal : Royal Victoria Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Montreal : Hopital Maisonneuve Rosemont
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Montreal : GSK Investigational Site
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Montreal : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Montreal : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Montreal : Local Institution
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Montreal : Jewish General Hospital, Site #129 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Montreal : Hopital du Sacre-Coeur de Montreal
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Ottawa : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Quebec : Hopital de L'Enfant-Jesus
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Québec : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Rimouski :
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Saint John : Atlantic Health Sciences Corporation Saint John Regional Hospital
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Saint John : Saint John Regional Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Sainte-Foy : Quebec Children's Hospital
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Sherbrooke : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
St. Catherine : Hospital St. Justine
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
St. John : Atlantic Health Sciences Corporation, Saint John Regional Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
St. Johns : Health Sciences Center
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
St. Johns : Health Sciences Center
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Toronto :
A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia
Toronto : Novartis Investigative Site
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Toronto : Univ. Health Network-Princess Margaret Hospital
A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia
Toronto : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Toronto : Sick Children's Hospital
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Toronto :
A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
Toronto : Princess Margaret Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Toronto : University Health Network-Princess Margaret Hospital
An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)
Toronto : Princess Margaret Hospital
Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy
Toronto : Research Site
CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Toronto : University Health Network, Princess Margaret Hospital
Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients
Toronto : Hospital for Sick Children
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Toronto : Novartis Investigative Site
Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy
Toronto : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Toronto : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Toronto : University Health Network - Princess Margaret Hospital
Open-Label Study of Lenalidomide in Combination With Oral Dexamethasone in the Treatment of Previously Untreated, Symptomatic Patients With Chronic Lymphocytic Leukemia
Toronto : University Health Network, Princess Margaret Hospital, Site #083 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Toronto : Princess Margaret Hospital
Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia
Toronto : Research Site
Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients
Toronto : Princess Margaret Hospital
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Toronto : Princess Margaret Hospital
Study Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Toronto : University Health Network, Princess Margaret Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Toronto : Hospital for Sick Kids
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Vancouver : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Vancouver : Leukemia BMT program of BC, Vancouver General Hospital, Hematology Research and Clinical Trials Unit
A Study Investigating the Predictive Value of Philadelphia Positive Stem Cell Properties in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase Receiving Treatment With Imatinib
Vancouver :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Vancouver : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Vancouver : Division of Hematology, Vancouver General Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Winnipeg : CancerCare Manitoba
A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia
Chile
Renaca : Instituto Oncologico Anabaena 336 Vina del Mar V Region
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Santiago :
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Temuco : Instituto Clinico Oncologico del Sur (ICOS) Lago Puyehue 01745 Temuco IX Region de La Araucania
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
China
Beijing :
A Study of RO5072759 (GA101) in Patients With CD20+-Malignant Lymphoma
Beijing : Beijing Clinical Service Center
Bortezomib in Combination With Liposomal Doxorubicin and Dexamethasone to Treat Plasma Cell Leukemia
Guangzhou :
A Study of RO5072759 (GA101) in Patients With CD20+-Malignant Lymphoma
Hong Kong : Department of Paediatrics and Adolescent Medicine, The University of Hong Kong
A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma
Shanghai :
A Study of RO5072759 (GA101) in Patients With CD20+-Malignant Lymphoma
View More »
Tianjin :
A Study of RO5072759 (GA101) in Patients With CD20+-Malignant Lymphoma
Tianjin : Hematologic hospital of Chinese academy of medical sciences
Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia
Colombia
Monteria : Novartis Investigative Site
Randomized ph Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib
Monteria : Oncomedica S.A
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Croatia
Zagreb :
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Zagreb : University Hospital Dubrava
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Czech Republic
Bmo : Pfizer Investigational Site
A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia
Brno : Lekarna fakultni nemocnice V Brne
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Brno : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Brno : FN Brno
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Brno : University Hospital Brno
Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia
View More »
Brno : Fakultni nemocnice Brno, Interni hematoonkologicka klinika
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Brno - Bohunice : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Hradec Kralove : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Hradec Kralove : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Hradec Kralove : FN Hradec Kralove
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Hradec Kralove : Faculty Hospital Hradec Kralove
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Hradec Kralove : Fakultni nemocnice Hradec Kralove, 2. Interni klinika-oddeleni klinicke hematologie
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Novy Jicin : Oncology Centre J.G. Mendela
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Olomouc : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Olomouc : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Olomouc : FN Olomouc
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Ostrava : Fakultni nemocnice Ostrava
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Plzen : Faculty Hospital Plzen
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Prague : General Faculty Hospital 1 - Internal Clinic
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Praha : VFN Praha 2
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Praha : FN Kralovske Vinohrady
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Praha : Ustavni lekarna Fakultni nemocnice Kralovske Vinoh
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Praha : Fakultni nemocnice Kralovske Vinohrady, Oddeleni klinicke hematologie
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Praha 2 : GSK Investigational Site
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Praha 2 : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Praha 2 : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Denmark
Aalborg : GSK Investigational Site
Observational Study of Nelarabine in Children and Young Adults
Copenhagen : Rigshospitalet University Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Copenhagen : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Copenhagen : Copenhagen University Hospital Rigshospital
Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)
Copenhagen : Rigshospitalet University Hospital
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
View More »
Herlev : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Herlev : Herlev Hospital
Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)
Herlev : Copenhagen University Hospital at Herlev
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Koebenhavn Oe : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Roskilde : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Vejle : Vejle Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Egypt
Cairo : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Finland
Pori :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Tampere : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Vantaa :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
France
Aix En Provence :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Albi :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Amiens : Groupe Hospitalier Sud
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Amiens : Hopital Nord
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Amiens : CHU Amiens
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
View More »
Amiens : CHU d'Amiens
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Amiens : Service d'hématologie pédiatrique CHRU
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Angers : Chu D'Angers
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Angers :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Angers : 1211 - CHU d'Angers
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Angers : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Angers : CHRU Angers
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Angers : CHU Angers
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Angers : Mathilde HUNAULT BERGER
Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)
Angers : CHU Angers Service de Medecine D - Maladies du Sang
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Angers Cedex 01 : CHU Angers, Service des maladies du sang
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Angers cedex 09 : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Antibes :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Argenteuil : CH Victor Dupouy
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Argenteuil :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Argenteuil : Hopital Victor Dupouy
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Argenteuil :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Arras :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Avignon :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Avignon :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Avignon : CHU Avignon Centre Hospitalier Henri Dufaut
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Bayonne : Ch de La Cote Basque
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Bayonne :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Bayonne : Centre hospitalier de la côte Basque
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Besancon : Hopital Saint Jacques
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Besancon : Hopital Jean Minjoz
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Besancon : CHU Hôpital Minjoz
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Besancon : Service hématologie pédiatrique Hôpital Saint-Jacques
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Besançon : 1210 - CHU de Besançon
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Beziers :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Blois :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Blois :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Blois cedex : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Bobigny : Hopital Avicenne
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Bobigny : Hopital Avicenne
A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q
Bobigny :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Bobigny : Hôpital Avicenne Hématologie Clinique
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Bobigny : Hopital Avicenne- Departement Onco-hematologie
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Bobigny Cedex : Novartis Investigative Site
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Bobigny Cedex : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Bordeaux : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Bordeaux : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Bordeaux : Service d'Hematologie - Institut Bergonié
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Bordeaux :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Bordeaux : Hopital Pellegrin Enfants
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Bordeaux :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Bordeaux : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Bordeaux : Novartis Investigative Site
Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy
Bordeaux : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Bordeaux : Service d'hémato-oncologie - Hôpital des Enfants Pellegrin
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Bordeaux cedex : GSK Investigational Site
Observational Study of Nelarabine in Children and Young Adults
Boulogne :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Bourg En Bresse :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Brest :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Brest :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Brest : CHU Morvan
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Brest : Hôpital Morvan
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Caen :
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Caen : Chu Cote de Nacre
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Caen :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Caen : CHU Caen Hématologie Clinique
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Caen : Hématologie oncologie pédiatrique-CHU Caen
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Caen cedex 5 : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Carcassonne :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Castelnau Lez :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Cedex : CHU Côte de Nacre
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Cergy Pontoise : 1206 - Hôpital de Pontoise
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Cergy Pontoise : CH René Dubos
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Chalon Sur Saone :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Chambery :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Clamart : Hôpital Militaire Percy
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Clermont : Service d'Hematolgie Clinique - CHU Estaing
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Clermont Ferrand : Chu Estaing
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Clermont Ferrand Cedex 1 :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Clermont-ferrand :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Clermont-Ferrand : CHU Hôtel Dieu
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Clermont-Ferrand : CHU Estaing
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Clermont-Ferrand : CHU Estaing Service d'hématologie
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Clermont-Ferrand : CHU de Clermont-Ferrand
Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia
Clermont-Ferrand : Hémato-Oncologie et Thérapie Cellulaire Pédiatrique - Hôtel Dieu
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Clermont-Ferrand Cedex 1 : GSK Investigational Site
Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia
Colmar :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Colmar : CH Louis Pasteur
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Corbeil Essonnes : Centre hospitalier sud francilien
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Corbeil-essonnes :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Courbevoie : Laboratoires Merck Sharp & Dohme - Chibret
A Study of Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974 AM1)
Creil :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Creteil :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Creteil : Hopital Henri Mondor
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Creteil : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Créteil : 1205 - CHU Henri Mondor
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Créteil : Hôpital Henri Mondor
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Dijon :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Dijon : Hopital Du Bocage
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Dijon : CHU du Bocage
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Dijon : Dijon hôpital d'enfants
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Dijon : Hémato-Oncologie Pédiatrique - Hôpital d'Enfants
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Frejus :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Grenoble : Chu Grenoble
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Grenoble :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Grenoble : CHU Michallon
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Grenoble : CHU de Grenoble
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Grenoble : Hôpital Michallon
Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia
Grenoble : Pédiatrie CHU - Hôpital Nord
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Grenoble : Hopital A Michalon
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Grenoble cedex 9 : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
La Roche Sur Yon :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
La Tronche :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
La Tronche :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Le Chesnay : Ch de Versailles - Hopital Mignot
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Le Chesnay : Hopital Mignot
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Le Mans :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Le Mans :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Lens :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Libourne :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Lille :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Lille : Chru Lille
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Lille : Chru Lille - Hop Jeanne de Flandres
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Lille : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Lille : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Lille : CHRU - Hopital Claude HURIEZ
Phase I Study of ONO-4059 Given as Monotherapy in Patients With Relapsed/Refractory NHL and CLL
Lille : CHU Lille Hôpital Claude Huriez
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Lille : Hôpital Jeanne de Flandre
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Lille : CHU Lille, Service des maladies du sang, Hopital Huriez
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Lille cedex : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Lille Cedex : GSK Investigational Site
Observational Study of Nelarabine in Children and Young Adults
Lille cedex : GSK Investigational Site
Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia
Limoges :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Limoges : Chu Dupuytren
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Limoges : CHU Dupuytren
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Limoges : CHU Limoges Hopital Dupuytren
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Limoges : Limoges University Hospital
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Lyon :
A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia
Lyon : Institut Hematologie Oncologie Pediatrique
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Lyon :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Lyon : 1209 - CHU de Lyon
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Lyon : Centre hospitalier Lyon Sud
Phase I Study of ONO-4059 Given as Monotherapy in Patients With Relapsed/Refractory NHL and CLL
Lyon : Hôpital Edouard Herriot
Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia
Lyon : Hôpital DEBROUSSE Institut d'hématologie et d'oncologie pédiatrique
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Lyon : Xavier THOMAS
Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia
Lyon Cedex : Hospital Edouard Herriot, Service d'Hematologie Clinique
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Lyon cedex 04 : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Lyon Cedex 08 : Novartis Investigative Site
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
Macon :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Marseille :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Marseille :
A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
Marseille : Chu Timone Enfants
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Marseille : Institut Paoli Calmettes
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Marseille :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Marseille : Institut Paoli Calmette
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Marseille : Novartis Investigative Site
Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy
Marseille : Institute Paoli Calmettes
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Marseille : Institut Paoli Calmettes
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Marseille Cedex 09 : 1270.1.33002 Boehringer Ingelheim Investigational Site
BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)
Marseille Cedex 09 : Institut Paoli - Calmettes
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Marseille Cedex 09 : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Marseille cedex 9 : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Marseille Cedex 9 : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Marseille Cedex 9 : Local Institution
Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Maseille : Service hématologie pédiatrique CHU la Timone
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Meaux : Centre Hospitalier de Meaux
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Meaux : CH de Meaux
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Metz :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Metz : CH Metz Thionvile
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Metz Tessy :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Montauban :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Montpellier :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Montpellier :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Montpellier : Investigational Site Number 250002
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Montpellier : Hopital Saint Eloi
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Montpellier :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Montpellier : CHU Lapeyronie
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Montpellier : Guillaume CARTRON
Intensified Rituimab Prephase Before FCR in Untreated B-CLL
Montpellier : CHU St Eloi
Phase I Study of ONO-4059 Given as Monotherapy in Patients With Relapsed/Refractory NHL and CLL
Montpellier : Hôpital Arnaud de Villeneuve
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Montpellier Cedex 5 : 1270.1.33001 Boehringer Ingelheim Investigational Site
BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)
Montpellier Cedex 5 : CHU Saint Eloi
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Mulhouse :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Mulhouse : Hopital Emile Muller
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Mulhouse :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Mulhouse : CH Muller
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Mulhouse : Centre Hospitalier de Mulhouse
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Mulhouse : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Nancy : CHU Brabois
A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q
Nantes :
A Study of RO5429083 Alone or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
Nantes : Hopital Mere Enfant
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Nantes : Hotel Dieu
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Nantes :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Nantes : Hôpital de l'hôtel Dieu
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Nantes : 1212 - Hôpital de l'hôtel Dieu
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Nantes : CHU Hôtel Dieu
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Nantes : CHU de Nantes
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Nantes : CHR Hôtel Dieu
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Nantes : CHU Nantes Hotel Dieu, Service d'hematologie clinique
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Nantes : Hospital Hotel Dieu, Service D'Hematologie
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Nantes Cedex : CHU Hotel Dieu
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Nantes Cedex 01 : Investigational Site Number 250006
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Nantes cedex 1 : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Nice :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Nice : Hopital de l'Archet 1
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Nice : Hopital de L'Archet 2
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Nice :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Nice : 1213 - Centre Hospitalier Universitaire de Nice
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Nice : Centre Antoine Lacassagne
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Nice : Hôpital de L'archet I
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Nice : Hôpital de l'Archet
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Nice : Hopital de l'Archet
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Nimes :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Nimes :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Nimes : CHU Carémeau
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Nimes Cedex : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Orleans :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Orléans : CH La Source
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Paris : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Paris :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Paris : Hopital Saint Louis
A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q
Paris : Novartis Investigative Site
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
Paris :
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Paris : Hopital Armand Trousseau
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Paris : Hopital Hotel Dieu
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Paris : Hopital Robert Debre
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Paris : Hopital Necker Enfants Malades
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Paris : Hopital Saint Louis
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Paris : Hopital Saint Antoine
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Paris :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Paris : 1201 - Hôpital Saint Louis
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Paris : Hopital Cochin (AP-HP)
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Paris : Hôpital Saint-Louis
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Paris : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Paris : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Paris : Hôpital Saint-Antoine
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Paris : Hôtel Dieu Sce Hématologie Clinique
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Paris : Service hématologie Hopital Necker
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Paris : Hématologie Pédiatrique - Hôpital Trousseau
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Paris : Hémato-immunologie-Robert Debré
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Paris : Children Armand Trousseau Hospital
Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2
Paris : Hospital Saint Louis, Service D'Hematologie
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Paris Cedex 10 : Local Institution
Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Paris cedex 12 : GSK Investigational Site
Observational Study of Nelarabine in Children and Young Adults
Paris Cedex 15 : Hôpital Necker
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Paris Cedex 19 : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Perpignan :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Perpignan : Ch de Perpignan
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Perpignan :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Perpignan : CH Saint-Jean
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Perpignan : CHU Perpignan Centre Hospitalier Hôpital Saint-Jean
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Pessac : Research Site
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Pessac : Hopital Haut-Leveque
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Pessac : 1202 - CHU de Bordeaux - Hôpital Haut Lévêque
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Pessac : CHU du Haut Lévèque
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Pessac : CHU de Bordeaux - Hôpital Haut-Lévêque
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Pessac : CHU de Bordeaux- Hopital Haut-Leveque, Centre Francois Magendle
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Pessac : CHU du Haut-Leveque, Service des Matadies du Sang Unite de Recherche Clinique
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Pessac cedex : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Pessac cedex : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Pierre Benite :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Pierre Benite :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Pierre Benite : Hopital Lyon Sud
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Pierre Benite :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Pierre Benite :
CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Pierre Benite : Centre Hospitalier Lyon Sud - Service d'Hematologie - Pavillon Marcel Berard - Bat. 1G - 1er etage, 165 Chemin du grand Revoyet
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Pierre Benite : Local Institution
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Pierre Bénite : Centre hospitalier Lyon Sud
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Pierre Benite Cedex : Investigational Site Number 250001
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Pierre Benite Cedex : CHU Lyon Sud
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Pierre-Bénite cedex : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Poitiers : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Poitiers : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Poitiers : CHU La Miletrie
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Poitiers :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Poitiers : CHU Jean Bernard - La Milétrie
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Poitiers : CHU de Poitiers
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Poitiers : Novartis Investigative Site
Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy
Poitiers : Hématologie Hôpital Jean Bernard
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Poitiers : University Hospital
STI571 ProspectIve RandomIzed Trial: SPIRIT
Pontoise : Centre Hospitalier Rene Dubos
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Pontoise :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Pringy : Ch de La Region D'Annecy
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Reims : Hopital Robert Debre
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Reims :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Reims : CHU Robert Debré
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Reims : Hématologie pédiatrique-Hopital américain
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Rennes : Investigational Site Number 250004
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Rennes : Chru Hopital Sud
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Rennes : Hopital de Pontchaillou
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Rennes :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Rennes : CHU Pontchaillou
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Rennes : Service d'hématologie pédiatrique - Hôpital Sud
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Roubaix :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Rouen :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Rouen : CLCC H Becquerel Hematology
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Rouen : Centre Henri Becquerel
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Rouen :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Rouen : Centre Henri Becquerel
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Rouen : Stephane LEPRETRE
Intensified Rituimab Prephase Before FCR in Untreated B-CLL
Rouen : CRLCC Henri Becquerel
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Rouen : Service d'Immuno Hémato Oncologie Pédiatrique - Hôpital Charles Nicolle
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Rouen Cedex : Investigational Site Number 250005
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Saint Brieuc :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Saint Etienne : Chu Hopital Nord
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Saint Etienne : Institut de Cancérologie de la Loire
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Saint Etienne : Hématologie, Oncologie pédiatrique-CHU Saint Etienne
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Saint Priest En Jarez : Institut Cancerologie de La Loire
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Saint Priest en Jarez Cedex : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Saint Quentin :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Saint-Cloud : Centre René Huguenin
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Saint-priest-en-jarez :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Saint-Quentin : CH Saint-Quentin
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Salon de Provence :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Salouel :
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Salouel :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
St Germain En Laye :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
St Herblain :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
St Priest en Jarez : Institut de Cancerologie de la Loire
Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia
Strasbourg : Hopital de Hautepierre
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Strasbourg :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Strasbourg : CHU Hautepierre
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Strasbourg : Hôpital Haute Pierre et Hôpital Civil
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Strasbourg : Chu-Strasbourg-Hopital Civil
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Strasbourg : Pédiatrie Hôpital Hautepierre
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Strasbourg : CHU Hautepierre
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Toulon :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Toulouse : Hopital de Purpan
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Toulouse : Chu de Toulouse Enfants
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Toulouse :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Toulouse : CHU de Purpan
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Toulouse :
CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Toulouse : 1208 - CHU de Purpan
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Toulouse : CHU Purpan
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Toulouse : CHU Purpan
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Toulouse : Hôpital Purpan
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Toulouse : Hopital des enfants
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Toulouse : Service d'hematologie- Hopital Purpan- CHU de Toulouse
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Toulouse Cedex 9 : 1270.1.33003 Boehringer Ingelheim Investigational Site
BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)
Toulouse cedex 9 : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Tours :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Tours : Hopital Bretonneau
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Tours :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Tours : CHU Bretonneau
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Tours : CHU- Centre Gatien de Clocheville
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Tours Cedex : Hopital Bretonneau
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Troyes :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Valence :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Valenciennes : Hotel Dieu
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Valenciennes : CH Valenciennes
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Vandoeuvre : Nancy University Hospital - Hôpitaux de Brabois
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Vandoeuvre Les Nancy : Hopital de Brabois
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Vandoeuvre Les Nancy : Hopital Brabois Enfants
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Vandoeuvre Les Nancy : CHU Brabois
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Vandoeuvre Les Nancy : CHU de Nancy Hôpitaux de Brabois
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Vandoeuvre les Nancy : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Vandoeuvre Les Nancy : Hôpital d'enfants
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Vandoeuvre-les-nancy :
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Vandoeuvre-Les-Nancy : GSK Investigational Site
Observational Study of Nelarabine in Children and Young Adults
Villejuif :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Villejuif Cedex : Investigational Site Number 250003
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Germany
Aachen : Universitätsklinikum Aachen, AÖR, Site #513 Updated
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
